falseFY000113595100P1YP1YP1YRevenues for the year ended March 31, 2025 do not include inter-segment revenues from the PSAI segment to the Global Generics segment, which amount to Rs.9,389 (as compared to Rs.10,707 and Rs.7,321 for the years ended March 31, 2024 and 2023, respectively) and from the PSAI segment to the Others segment which amount to Rs.0 (as compared to Rs.72 and Rs.128 for the years ended March 31, 2024 and 2023, respectively) As the revenues and gross profits of the Proprietary Products segment are considerably lower than the quantitative thresholds mentioned in IFRS 8, “Operating Segments”, the Company believes that Proprietary Products segment no longer qualifies to be a reportable segment and consequently, effective April 1, 2022, the Company included the financial information relating to the Proprietary Products segment in “Others”. The corresponding information relating to Proprietary Products segment for earlier periods has been restated to reflect the aforementioned change.Others include Germany, the United Kingdom, Ukraine, Romania, Brazil, South Africa, China, Canada and other countries across the world.During the year ended March 31, 2022, there was a significant decline in expected cash flows of the Company’s subsidiary, Dr. Reddy’s Laboratories Louisiana, LLC (the Shreveport Cash Generating Unit or “CGU”) resulting in the recoverable amount of the CGU being lower than it’s carrying amount. Accordingly, the Company recognized an impairment loss for the entire carrying value of Rs.2,570 for property, plant, and equipment, Rs.89 for capital work-in-progress and Rs.392 for goodwill. Further, impairment losses of Rs.94, representing additions to property, plant, and equipment in subsequent years, have been recognized as the recoverable amount continues to be lower than the carrying value.Refer to Note 36 of these consolidated financial statements for details regarding goodwill arising on business combinations.Primarily represents the investment in shares of Curis, Inc. The cost of acquisition was Rs.2,699. As of March 31, 2025 and 2024, the Company has recognized an unrealized loss of Rs.2,651 and Rs.2,451, respectively, in the OCI for the fair value changes.Balances and receivables from statutory authorities primarily consist of amounts recoverable towards the goods and service tax (“GST”), value added tax, and from customs authorities of India.Primarily consist of amounts receivable from various government authorities of India towards incentives on export sales made by the Company and other incentives.Others primarily includes claims receivable and security deposits. During the year ended March 31, 2024, Others primarily includes advances to vendorsIncludes Rs.181 representing the goodwill on acquisition of investment.BRL” means Brazilian reals, “EUR” means Euro, “INR” means Indian rupees, “MXN” means Mexican pesos, “RUB” means Russian rubles and “U.S.$” means U.S. dollars.“CDI” means Brazilian interbank deposit rate (Certificado de Depósito Interbancário), “Key rate” means the key interest rate published by the Central Bank of Russia, “SOFR” means Secured Overnight Financing Rate, “T-bill” means India Treasury bill interest rate and  “TIIE” means the Equilibrium Inter-banking Interest Rate (Tasa de Interés Interbancaria de Equilibrio).The Rupee term loan obtained from a bank by the Company’s subsidiary, Aurigene Pharmaceutical Services Limited is subject to certain covenants that are required to be maintained on a consolidated basis during the period of the loan. The covenant is to be tested on an annual basis at the end of each financial year. As at March 31, 2025 and March 31, 2024, the Company is in compliance with the covenants and has no indication that it will have difficulty in complying with the same.Includes current portion.Does not include movement in bank overdraft.The Board of Directors of the Company at their meeting held on July 27,2024 approved the sub-division/ stock split of each equity share having a face value of Rupees five each, fully paid-up, into five equity shares having a face value of Rupee One each, fully paid-up (the “stock split”), by alteration of the capital clause of the Memorandum of Association of the Company. Further, each American Depositary Share (“ADS”) of the Company continued to represent one underlying equity share and, therefore, the number of ADSs held by an American Depositary Receipt (“ADR”) holder consequently increased in proportion to the increase in number of equity shares. On September 12, 2024, the approval of the shareholders of the Company was obtained through a postal ballot process with a requisite majority. Consequently, the authorized share capital, the outstanding shares and Treasury shares were sub-divided into equity shares having a face value of Rupees One each effective as of the record date of October 28, 2024.Excluding dividend paid on treasury sharesEarnings per share is computed after giving effect to 1:5 forward stock split effective October 28, 2024 for all periods presented. Refer to Note 20 of these consolidated financial statements for further details regarding such stock split.As of March 31, 2025, 2024 and 2023, 941,080, 1,227,725 and 1,432,665 options, respectively, were excluded from the diluted weighted average number of equity shares calculation because their effect would have been anti-dilutive. The average market value of the Company’s shares for the purpose of calculating the dilutive effect of stock options was based on quoted market prices for the year during which the options were outstanding.Pursuant to approval by the Nomination, Governance and Compensation Committee, 37,268 granted options were cancelled on October 27, 2022.Includes earn-out consideration payable to Haleon UK Enterprises Limited. Refer to Note 36.B of these consolidated financial statements for further details. Primarily consists of provision recorded towards the potential liability arising out of a litigation relating to cardiovascular and anti-diabetic formulations. Refer to Note 32 (“Contingencies”) of these consolidated financial statements under “Product and patent related matters - Matters relating to National Pharmaceutical Pricing Authority and Litigation relating to Cardiovascular and Anti-diabetic formulations” for further details.As a result of the acquisition of a unit of The Dow Chemical Company in April 2008, the Company assumed a liability for contamination of the Mirfield site acquired of Rs.39 (carrying value Rs.61). The seller is required to indemnify the Company for this liability. Accordingly, a corresponding asset has also been recorded in the consolidated statements of financial position.Refund liability is accounted for by recording a provision based on the Company’s estimate of expected sales returns. See Note 3.m of these consolidated financial statements for the Company’s accounting policy on refund liability.Refer to Note 22 (“Revenue from contracts with customers and trade receivables”) of these consolidated financial statements for details of deferred revenue. During the year ended March 31, 2025, the license fees includes an amount of Rs.1,266 (U.S.$15) as a milestone payment receivable upon U.S. FDA approval of DFD 29, in accordance with the license and collaboration agreement dated June 29, 2021 with Journey Medical Corporation. This transaction pertains to the Company’s Others segment.(a) Gain on sale of non-current assets during the year ended March 31, 2025 includes: - a cumulative foreign exchange gain of Rs.1,551, reclassified from the foreign currency translation reserve to the income statement, and - a loss of Rs.52 due to turnaround fees paid to the buyer upon divestment of the membership interest Dr. Reddy’s Laboratories Louisiana LLC. Refer to Note 12 (“Property, Plant and Equipment”) of these consolidated financial statements for further details. (b) Miscellaneous income for the year ended March 31, 2023 include an amount of Rs.991 (EUR 11.36) representing the loss on sale of assets, pursuant to an agreement with Delpharm Development Leiden B.V for the transfer of certain assets, liabilities and employees at its site at Leiden, Netherlands. This transaction pertains to the Company’s Global Generics segment.Other assets that are not financial assets (such as receivables from statutory authorities, export benefit receivables, prepaid expenses, advances paid and certain other receivables) of Rs.20,598 and Rs.15,191 as of March 31, 2024 and 2023, respectively, are not included.Other liabilities and provisions that are not financial liabilities (such as statutory dues payable, deferred revenue, advances from customers and certain other accruals) of Rs.17,156 and Rs.16,907 as of March 31, 2024 and 2023, respectively, are not included. Other liabilities and provisions includes amount measured at amortized cost of Rs.30,388 and Rs.26,023 as of March 31, 2024 and 2023, respectively, and contingent consideration measured at FVTPL of Rs.187 and Rs.187 as of March 31, 2024 and 2023, respectively.The Company enters into derivative financial instruments with various counterparties, principally financial institutions and banks. Derivatives which are valued using valuation techniques with market observable inputs are mainly interest rate swaps, foreign exchange forward option and swap contracts. The most frequently applied valuation techniques include forward pricing, swap models and Black-Scholes-Merton models (for option valuation), using present value calculations. The models incorporate various inputs, including foreign exchange forward rates, interest rate curves and forward rate curves.Other primarily consists of Swiss francs, U.K. pounds sterling, Chinese yuans (Renminbi) and Romanian leu.Others primarily consists of Romanian new leus, Chinese yuans (Renminbi), U.K. pounds sterling and Japanese yen.Rounded to the nearest million.The Company has created a Special Economic Zone (“SEZ”) Reinvestment Reserve out of profits of its eligible SEZ Units in accordance with the terms of Section 10AA(1) of the Indian Income Tax Act, 1961. This reserve was utilized by the Company for acquiring plant and machinery in accordance with Section 10AA(2) of such Act.The Company has created a Debenture Redemption Reserve out of profits of its subsidiary Aurigene Pharmaceutical Services Limited that issued debentures in accordance with the terms of Section 18(7)(iv) & 18(7)(v) AA(1) of the of Companies (Share Capital and Debentures) Rules, 2014. This reserve is to be utilized by the Company for redemption of debentures. During the year ended March 31, 2024, upon redemption of debentures the Company has transferred the balance from the Debenture Redemption Reserve to Retained earnings.Represents mark to market gain or loss on financial assets classified as fair value through other comprehensive income (“FVTOCI”).  Depending on the category and type of the financial asset, the mark to market gain or loss is either reclassified to the income statement or to retained earnings upon disposal of the investment. Refer to Note 33 (“Merger of Dr. Reddy’s Holdings Limited into Dr. Reddy’s Laboratories Limited”) of these consolidated financial statements.Following the acquisition of a non-controlling interest (“NCI”) in the Nutraceuticals subsidiary by Nestle India, the difference between cash consideration received from such NCI and the proportionate share of net assets is recognized in “Other reserves” within equity.Pursuant to the special resolution approved by the shareholders in the Annual General Meeting held on July 27, 2018, the Dr. Reddy’s Employees ESOS Trust (the “ESOS Trust”) was formed to support the Dr. Reddy’s Employees Stock Option Scheme, 2018 by acquiring, from the Company or through secondary market acquisitions, equity shares which are used for issuance to eligible employees (as defined therein) upon exercise of stock options thereunder. During the years ended March 31, 2024 and 2023, an aggregate of 81,353 and 49,295 equity shares, respectively were issued as a result of the exercise of vested options granted to employees pursuant to the Dr. Reddy’s Employees Stock Option Scheme, 2018. The options exercised had an exercise price of Rs.2,607, Rs.2,814, Rs.3,679, Rs.4,212, Rs.4,338 or Rs,5,301 per share. Upon the exercise of such options, the amount of compensation cost (computed using the grant date fair value) previously recognized in the “share based payment reserve” was transferred to “securities premium” in the statement of changes in equity. In addition, any difference between the carrying amount of treasury shares and the consideration received was recognized in the “securities premium”. During the year ended March 31, 2023, an aggregate of 48,032 equity shares representing unappropriated inventory of shares that are not backed by grants, acquired through secondary market acquisitions were sold for an aggregate consideration of Rs.211 in the secondary market pursuant to requirements under Chapter II Regulation 3(12) of the SEBI (share based employee benefits and sweat equity) Regulations, 2021.The Company’s overall provision for refund liability as of March 31, 2025 relating to the Company’s North America Generics business was U.S.$41, compared to a liability of U.S.$35 as of March 31, 2024. The refund liability created for new product launches and volume growth, were off-set by the reductions in the contract prices and by product mix changes.The Company had created a Debenture Redemption Reserve out of profits of its subsidiary Aurigene Pharmaceutical Services Limited that issued debentures in accordance with the terms of Sections 18(7)(iv) and 18(7)(v) AA(1) of the Companies (Share Capital and Debentures) Rules, 2014. During the year ended March 31, 2024, upon redemption of debentures the Company has transferred the balance from the Debenture Redemption Reserve to Retained earnings.Adjusted for bank overdraft of Rs.61 for the year ended March 31, 2025.Pursuant to the special resolution approved by the shareholders in the Annual General Meeting held on July 27, 2018, the Dr. Reddy’s Employees ESOS Trust (the “ESOS Trust”) was formed to support the Dr. Reddy’s Employees Stock Option Scheme, 2018 by acquiring, from the Company or through secondary market acquisitions, equity shares which are used for issuance to eligible employees (as defined therein) upon exercise of stock options thereunder. During the year ended March 31, 2025, 1,168,490 shares were acquired from the open market. The total amount paid to acquire these shares was Rs. 1,389. During the years ended March 31, 2025 and March 31, 2024, an aggregate of 22,077 (prior to stock split) and 54,800 (after stock split) and 81,353 equity shares, respectively, were issued as a result of the exercise of vested options granted to employees pursuant to the Dr. Reddy’s Employees Stock Option Scheme, 2018. The options exercised had an exercise price of Rs. 2,607, Rs. 2,814, Rs. 3,679, Rs. 3,906, Rs. 4,212, Rs. 4,663 or Rs, 5,301 (prior to stock split) and Rs.521, Rs.563, Rs.736, Rs. 886, Rs.933, Rs.981 and Rs. 1,060 (after stock split) per share. Upon the exercise of such options, the amount of compensation cost (computed using the grant date fair value) previously recognized in the “share based payment reserve” was transferred to “securities premium” in the statement of changes in equity. In addition, any difference between the carrying amount of treasury shares and the consideration received was recognized in the “securities premium.”Currently, the Company does not separately track provisions and adjustments, in each case to the extent relating to prior years for chargebacks. However, the adjustments are expected to be non-material. The volumes used to calculate the closing balance of chargebacks represent approximately 1.0 to 1.4 months equivalent of sales, which corresponds to the pending chargeback claims yet to be processed.Fair value of these instruments is determined based on an independent valuation report, which uses the net asset value method.Indirectly owned through Aurigene Oncology Limited (Formerly, Aurigene Discovery Technologies Limited).Indirectly owned through Reddy Holding GmbH. Indirectly owned through Dr. Reddy’s Laboratories SA.Indirectly owned through North Star Switzerland SARL.Accounted using equity method as per IAS 28, “Investment in Associates and Joint Ventures”.Indirectly owned through Dr. Reddy’s Laboratories Inc.Indirectly owned through Dr. Reddy’s Laboratories (EU) Limited. Chargebacks provisions and payments for the year ended March 31, 2025 were each lower as compared to the year ended March 31, 2024, primarily as a result of reduction in the invoice price to wholesalers for few of the Company’s major products. This was offset to some extent due to higher pricing rates on account of reductions in the contract prices through which the product is resold in the retail part of the supply chain for certain of the Company’s products.Chargebacks provisions and payments for the year ended March 31, 2024 were each higher as compared to the year ended March 31, 2023, primarily as a result of the Company’s acquisition of a U.S. generic prescription products portfolio from Mayne Pharma Group Limited in April 2023, higher sales volumes and also due to higher pricing rates per unit for chargebacks. Such higher pricing rates were on account of reductions in the contract prices through which the product is resold in the retail part of the supply chain for certain of our products. Chargebacks provisions and payments for the year ended March 31, 2024 were each higher as compared to the year ended March 31, 2023, primarily as a result of the Company’s acquisition of a U.S. generic prescription products portfolio from Mayne Pharma Group Limited in April 2023, higher sales volumes and also due to higher pricing rates per unit for chargebacks. Such higher pricing rates were on account of reductions in the contract prices through which the product is resold in the retail part of the supply chain for certain of the Company’s products. The rebate provisions and payments for the year ended March 31, 2024 were each higher as compared to the year ended March 31, 2023, primarily as a result of the aforesaid generic portfolio acquisition from Mayne Pharma Group Limited, as well as higher sales volumes for the Company’s base portfolio products.Chargebacks provisions and payments for the year ended March 31, 2023 were each higher as compared to the year ended March 31, 2022, primarily as a result of higher sales volumes and also due to higher pricing rates per unit for chargebacks on account of reductions in the contract prices through which the product is resold in the retail part of the supply chain for certain of the Company’s products. The foregoing were partially off-set due to a lower pricing rates per unit for chargebacks, primarily on account of a reduction in the invoice price to wholesalers for certain of the Company’s products. The rebate provisions and payments for the year ended March 31, 2023 were each lower as compared to the year ended March 31, 2022, primarily as a result of lower pricing rates per unit for rebates, due to reduction in the contract prices through which the product is resold in the retail part of the supply chain for certain of the Company’s products.Chargebacks provisions and payments for the year ended March 31, 2024 were each higher as compared to the year ended March 31, 2023, primarily as a result of the Company’s acquisition of a U.S. generic prescription products portfolio from Mayne Pharma Group Limited in April 2023, higher sales volumes and also due to higher pricing rates per unit for chargebacks. Such higher pricing rates were on account of reductions in the contract prices through which the product is resold in the retail part of the supply chain for certain of the Company’s products.Currently, the Company does not separately track the credits and payments, in each case to the extent relating to prior years for chargebacks, rebates, Medicaid payments or refund liability.Kunshan Rotam Reddy Pharmaceutical Co. Limited and Kunshan Rotam Reddy Medicine Company Limited are subsidiaries as per Indian Companies Act, 2013, as the Company holds a 51.33% stake. However, the Company accounts for this investment by the equity method and does not consolidate it in the Company’s financial statements.“INR” means Indian rupees.Reversal of impairment on capitalization of assets for the Shreveport Cash Generating Unit.“T-bill” means India Treasury bill interest rate.Miscellaneous income for the year ended March 31, 2024 includes: - Rs.984 recognized pursuant to a settlement of product related litigation by the Company and its affiliates in the United Kingdom; and - Rs.540 recognized pursuant to a settlement agreement with Janssen Group, in settlement of the claim brought in the Federal Court of Canada by the Company and its affiliates for damages under section 8 of the Canadian Patented Medicines (Notice of Compliance) Regulations in regard to the Company’s ANDS for a generic version of Zytiga® (Abiraterone).Includes reclassification of cumulative amount of foreign exchange gain from Foreign currency translation reserve to the income statement upon divestment or liquidation of foreign operations during the year ended March 31, 2025. Refer to Note 23 of these consolidated financial statements for details.Refer to Note 36.A of these consolidated financial statements for details regarding non-controlling interests.Refer to Note 36.B of these consolidated financial statements for details regarding cash flow hedge gain.Represents gain on disposal of equity instrument classified as FVTOCI instrument, which was subsequently classified to retained earnings.Fair value through profit and lossDuring the years ended March 31, 2025, and March 31, 2024, equity shares were issued as a result of the exercise of vested options granted to employees pursuant to the Dr. Reddy’s Employees Stock Option Scheme, 2002 and the Dr. Reddy’s Employees Stock Option Scheme, 2007. The options exercised had an exercise price of Rs. 5, Rs. 1,982, Rs. 2,607, Rs. 2,814, Rs. 3,679 or Rs. 5,301 (prior to stock split) and Rs.1 (after stock split) per share. Upon the exercise of such options, the amount of compensation cost (computed using the grant date fair value) previously recognized in the “share based payment reserve” was transferred to “securities premium” in the Consolidated Statement of Changes in Equity. 0001135951 2024-04-01 2025-03-31 0001135951 2024-03-31 0001135951 2025-03-31 0001135951 2022-04-01 2023-03-31 0001135951 2023-04-01 2024-03-31 0001135951 2023-03-31 0001135951 2024-01-29 2024-01-29 0001135951 2024-11-04 2024-11-04 0001135951 2006-04-01 2009-03-31 0001135951 2009-04-01 2011-03-31 0001135951 2011-04-01 2014-03-31 0001135951 2023-05-10 2023-05-10 0001135951 2024-05-06 2024-05-06 0001135951 2023-10-26 2023-10-26 0001135951 2022-02-28 2022-02-28 0001135951 2020-01-31 0001135951 2020-01-31 2020-01-31 0001135951 2024-08-01 2024-08-01 0001135951 2024-08-01 0001135951 2022-03-31 0001135951 ifrs-full:OrdinarySharesMember 2024-03-31 0001135951 rdy:ParentCompanyGratuityPlanMember 2024-03-31 0001135951 rdy:BankOverdraftMember 2024-03-31 0001135951 rdy:OtherWorkingCapitalBorrowingsMember 2024-03-31 0001135951 rdy:PreshipmentCreditMember 2024-03-31 0001135951 ifrs-full:KeyManagementPersonnelOfEntityOrParentMember 2024-03-31 0001135951 rdy:KunshanRotamReddyPharmaceuticalsCompanyLimitedMember 2024-03-31 0001135951 rdy:DresEnergyPrivateLimitedMember 2024-03-31 0001135951 rdy:GreenParkHotelsAndResortsLimitedMember 2024-03-31 0001135951 rdy:StamloIndustriesLimitedMember 2024-03-31 0001135951 rdy:ZenfoldSustainableTechnologyPrivateLimitedMember 2024-03-31 0001135951 rdy:GreenParkHospitalityServicesPrivateLimitedMember 2024-03-31 0001135951 rdy:IndusProjectsPrivateLimitedMember 2024-03-31 0001135951 rdy:AssetTypeMember 2024-03-31 0001135951 rdy:KunshanRotamReddyPharmaceuticalsCoLimitedMember 2024-03-31 0001135951 rdy:LaterThanFourYearsMember 2024-03-31 0001135951 ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember 2024-03-31 0001135951 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember 2024-03-31 0001135951 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember 2024-03-31 0001135951 ifrs-full:NotLaterThanOneYearMember 2024-03-31 0001135951 rdy:FundsManagedByInsurersMember rdy:ParentCompanyGratuityPlanMember 2024-03-31 0001135951 rdy:IndiaCountryMember 2024-03-31 0001135951 rdy:SwitzerlandCountryMember 2024-03-31 0001135951 country:US 2024-03-31 0001135951 rdy:GermanyCountryMember 2024-03-31 0001135951 rdy:OtherCountriesMember 2024-03-31 0001135951 ifrs-full:FinancialAssetsImpairedMember ifrs-full:LaterThanOneYearMember 2024-03-31 0001135951 ifrs-full:FinancialAssetsImpairedMember ifrs-full:NotLaterThanOneYearMember 2024-03-31 0001135951 ifrs-full:FinancialAssetsPastDueButNotImpairedMember ifrs-full:NotLaterThanOneYearMember 2024-03-31 0001135951 ifrs-full:FinancialAssetsPastDueButNotImpairedMember ifrs-full:LaterThanOneYearMember 2024-03-31 0001135951 rdy:NeitherPastDueMember ifrs-full:FinancialAssetsPastDueButNotImpairedMember 2024-03-31 0001135951 ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember rdy:OtherCashgeneratingUnitsMember 2024-03-31 0001135951 ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember rdy:GlobalGenericsNorthAmericaOperationsMember 2024-03-31 0001135951 ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember rdy:GlobalGenericsBrandedFormulationsMember 2024-03-31 0001135951 ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember 2024-03-31 0001135951 ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember rdy:PsaiActivePharmaceuticalOperationsMember 2024-03-31 0001135951 ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember rdy:GlobalGenericsComplexInjectablesMember 2024-03-31 0001135951 ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember rdy:GlobalGenericsConsumerHealthcareBusinessMember 2024-03-31 0001135951 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember 2024-03-31 0001135951 ifrs-full:LaterThanFiveYearsMember 2024-03-31 0001135951 ifrs-full:GrossCarryingAmountMember 2024-03-31 0001135951 rdy:GratuityBenefitsOfParentMember 2024-03-31 0001135951 rdy:NonderivativeFinancialInstrumentsMember srt:OtherCurrencyMember 2024-03-31 0001135951 rdy:ForeignCurrencyRiskFromNonderivativeFinancialInstrumentsMember 2024-03-31 0001135951 rdy:NonderivativeFinancialInstrumentsMember rdy:UsDollarsMember 2024-03-31 0001135951 rdy:NonderivativeFinancialInstrumentsMember rdy:EurosMember 2024-03-31 0001135951 rdy:NonderivativeFinancialInstrumentsMember rdy:RussianRoublesMember 2024-03-31 0001135951 rdy:NoncurrentAssetsMember 2024-03-31 0001135951 rdy:AurigenePharmaceuticalServicesLimitedMember 2024-03-31 0001135951 rdy:EmployeeBenefitObligationsMember rdy:ParentCompanyGratuityPlanMember 2024-03-31 0001135951 ifrs-full:RecurringFairValueMeasurementMember rdy:InvestmentInEquityMember 2024-03-31 0001135951 ifrs-full:RecurringFairValueMeasurementMember rdy:InvestmentInMfMember 2024-03-31 0001135951 ifrs-full:RecurringFairValueMeasurementMember rdy:InvestmentInLimitedLiabilityPartnershipFirmMember 2024-03-31 0001135951 ifrs-full:Level1OfFairValueHierarchyMember ifrs-full:RecurringFairValueMeasurementMember rdy:InvestmentInEquityMember 2024-03-31 0001135951 ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:RecurringFairValueMeasurementMember rdy:InvestmentInEquityMember 2024-03-31 0001135951 ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:RecurringFairValueMeasurementMember rdy:InvestmentInEquityMember 2024-03-31 0001135951 ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:RecurringFairValueMeasurementMember rdy:InvestmentInLimitedLiabilityPartnershipFirmMember 2024-03-31 0001135951 ifrs-full:Level1OfFairValueHierarchyMember ifrs-full:RecurringFairValueMeasurementMember rdy:InvestmentInMfMember 2024-03-31 0001135951 ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:RecurringFairValueMeasurementMember rdy:InvestmentInMfMember 2024-03-31 0001135951 ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:RecurringFairValueMeasurementMember rdy:InvestmentInMfMember 2024-03-31 0001135951 ifrs-full:Level1OfFairValueHierarchyMember ifrs-full:RecurringFairValueMeasurementMember rdy:InvestmentInLimitedLiabilityPartnershipFirmMember 2024-03-31 0001135951 ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:RecurringFairValueMeasurementMember rdy:InvestmentInLimitedLiabilityPartnershipFirmMember 2024-03-31 0001135951 rdy:ComponentOfEquityBeforeTaxAdjustmentMember 2024-03-31 0001135951 rdy:EquitySettledShareBasedPaymentExpenseMember rdy:DrlTwoThousandEighteenPlanMember 2024-03-31 0001135951 rdy:CategoriesBMember rdy:Drl2007PlansMember 2024-03-31 0001135951 rdy:CategoriesAMember rdy:Drl2007PlansMember 2024-03-31 0001135951 rdy:AdjustmentOfRecognisedDirectlyInEquityMember 2024-03-31 0001135951 rdy:InvestmentInEquitySecuritiesMember rdy:AtFairValueOrAmortizedCostMember 2024-03-31 0001135951 rdy:BondMember rdy:AdjustmentOfRecognisedDirectlyInEquityMember 2024-03-31 0001135951 rdy:BondMember rdy:AtFairValueOrAmortizedCostMember 2024-03-31 0001135951 rdy:TermDepositsWithBanksMember rdy:AtFairValueOrAmortizedCostMember 2024-03-31 0001135951 rdy:InvestmentInCommercialPaperMember rdy:AtFairValueOrAmortizedCostMember 2024-03-31 0001135951 rdy:AtFairValueOrAmortizedCostMember ifrs-full:InvestmentFundsMember 2024-03-31 0001135951 rdy:OthersInvestmentMember rdy:AtFairValueOrAmortizedCostMember 2024-03-31 0001135951 rdy:AtFairValueOrAmortizedCostMember 2024-03-31 0001135951 rdy:TermDepositsWithBanksMember rdy:AdjustmentOfRecognisedDirectlyInEquityMember 2024-03-31 0001135951 rdy:InvestmentInCommercialPaperMember rdy:AdjustmentOfRecognisedDirectlyInEquityMember 2024-03-31 0001135951 rdy:InvestmentInCommercialPaperMember ifrs-full:AtCostMember 2024-03-31 0001135951 rdy:OthersInvestmentMember ifrs-full:AtCostMember 2024-03-31 0001135951 rdy:BondMember ifrs-full:AtCostMember 2024-03-31 0001135951 rdy:AdjustmentOfRecognisedDirectlyInEquityMember ifrs-full:InvestmentFundsMember 2024-03-31 0001135951 ifrs-full:AtCostMember ifrs-full:InvestmentFundsMember 2024-03-31 0001135951 rdy:OthersInvestmentMember rdy:AdjustmentOfRecognisedDirectlyInEquityMember 2024-03-31 0001135951 rdy:TermDepositsWithBanksMember ifrs-full:AtCostMember 2024-03-31 0001135951 ifrs-full:AtCostMember 2024-03-31 0001135951 rdy:InvestmentInEquitySecuritiesMember rdy:AdjustmentOfRecognisedDirectlyInEquityMember 2024-03-31 0001135951 rdy:InvestmentInEquitySecuritiesMember ifrs-full:AtCostMember 2024-03-31 0001135951 rdy:InvestmentInLimitedLiabilityPartnershipMember rdy:AdjustmentOfRecognisedDirectlyInEquityMember 2024-03-31 0001135951 rdy:InvestmentInLimitedLiabilityPartnershipMember ifrs-full:AtCostMember 2024-03-31 0001135951 rdy:DepositsWithBanksAndFinancialInstitutionMember rdy:AtFairValueOrAmortizedCostMember 2024-03-31 0001135951 rdy:DepositsWithBanksAndFinancialInstitutionMember ifrs-full:AtCostMember 2024-03-31 0001135951 rdy:DepositsWithBanksAndFinancialInstitutionMember rdy:AdjustmentOfRecognisedDirectlyInEquityMember 2024-03-31 0001135951 rdy:InvestmentInLimitedLiabilityPartnershipMember rdy:AtFairValueOrAmortizedCostMember 2024-03-31 0001135951 rdy:TotalFairValueMember 2024-03-31 0001135951 rdy:CardiovascularMember 2024-03-31 0001135951 rdy:CompensatedAbsencesMember 2024-03-31 0001135951 rdy:CategoryBParValueOptionsMember rdy:Drl2002PlanMember rdy:ExercisepricesRs5Member 2024-03-31 0001135951 rdy:CategoryBParValueOptionsMember rdy:DrlTwoThousandSevenPlanMember rdy:ExercisepricesRs5Member 2024-03-31 0001135951 rdy:ForwardContractGbpUsBuyMember rdy:ContractTwelveMember rdy:HedgesOfRecognisedAssetsAndLiabilitiesMember 2024-03-31 0001135951 rdy:ForwardContractUsAudBuyMember rdy:ContractThirteenMember rdy:HedgesOfRecognisedAssetsAndLiabilitiesMember 2024-03-31 0001135951 rdy:OptionContractUsInrSellMember rdy:ContractFourteenMember rdy:HedgesOfRecognisedAssetsAndLiabilitiesMember 2024-03-31 0001135951 rdy:OptionContractRubUsDollarSellMember rdy:ContractFifteenMember rdy:HedgesOfRecognisedAssetsAndLiabilitiesMember 2024-03-31 0001135951 rdy:CurrencySwapEurBrlBuyMember rdy:ContractSixteenMember rdy:HedgesOfRecognisedAssetsAndLiabilitiesMember 2024-03-31 0001135951 rdy:ForwardContractUsInrSellMember rdy:ContractSeventeenMember rdy:HedgesOfHighlyProbableForecastedTransactionsMember 2024-03-31 0001135951 rdy:ForwardContractEurInrSellMember rdy:ContractSixMember rdy:HedgesOfRecognisedAssetsAndLiabilitiesMember 2024-03-31 0001135951 rdy:ForwardContractUsBrlBuyMember rdy:ContractSevenMember rdy:HedgesOfRecognisedAssetsAndLiabilitiesMember 2024-03-31 0001135951 rdy:ForwardContractUsClpBuyMember rdy:ContractEightMember rdy:HedgesOfRecognisedAssetsAndLiabilitiesMember 2024-03-31 0001135951 rdy:ForwardContractUsCopBuyMember rdy:ContractNineMember rdy:HedgesOfRecognisedAssetsAndLiabilitiesMember 2024-03-31 0001135951 rdy:ForwardContractUsRonBuyMember rdy:ContractTenMember rdy:HedgesOfRecognisedAssetsAndLiabilitiesMember 2024-03-31 0001135951 rdy:ForwardContractEurUsBuyMember rdy:ContractElevenMember rdy:HedgesOfRecognisedAssetsAndLiabilitiesMember 2024-03-31 0001135951 rdy:ForwardContractRubInrSellMember rdy:ContractOneMember rdy:HedgesOfRecognisedAssetsAndLiabilitiesMember 2024-03-31 0001135951 rdy:ForwardContractUsInrSellMember rdy:ContractTwoMember rdy:HedgesOfRecognisedAssetsAndLiabilitiesMember 2024-03-31 0001135951 rdy:ForwardContractZarInrSellMember rdy:ContractThreeMember rdy:HedgesOfRecognisedAssetsAndLiabilitiesMember 2024-03-31 0001135951 rdy:ForwardContractGbpinrSellMember rdy:ContractFourMember rdy:HedgesOfRecognisedAssetsAndLiabilitiesMember 2024-03-31 0001135951 rdy:ForwardContractAudInrSellsMember rdy:ContractFiveMember rdy:HedgesOfRecognisedAssetsAndLiabilitiesMember 2024-03-31 0001135951 rdy:ForwardContractRubInrSellMember rdy:ContractEighteenMember rdy:HedgesOfHighlyProbableForecastedTransactionsMember 2024-03-31 0001135951 rdy:OptionContractUsInrSellMember rdy:ContractNineteenMember rdy:HedgesOfHighlyProbableForecastedTransactionsMember 2024-03-31 0001135951 rdy:OptionContractRubUsDollarSellMember rdy:ContractTwentyMember rdy:HedgesOfHighlyProbableForecastedTransactionsMember 2024-03-31 0001135951 rdy:UnutilizedCreditLimitsMember 2024-03-31 0001135951 ifrs-full:CashFlowHedgesMember 2024-03-31 0001135951 rdy:LoanOneMember ifrs-full:FloatingInterestRateMember 2024-03-31 0001135951 rdy:LoanTwoMember ifrs-full:FloatingInterestRateMember 2024-03-31 0001135951 rdy:LoanThreeMember ifrs-full:FloatingInterestRateMember 2024-03-31 0001135951 rdy:InvestmentInUnquotedEquitySharesMember rdy:CleanRenewableEnergyKK2APrivateLimitedMember 2024-03-31 0001135951 rdy:InvestmentInUnquotedEquitySharesMember rdy:DresEnergyPrivateLimitedMember 2024-03-31 0001135951 rdy:InvestmentInUnquotedEquitySharesMember rdy:KunshanRotamReddyPharmaceuticalsCoLimitedMember 2024-03-31 0001135951 rdy:InvestmentInUnquotedEquitySharesMember 2024-03-31 0001135951 rdy:DresEnergyPrivateLimitedMember 2024-03-31 0001135951 ifrs-full:Level1OfFairValueHierarchyMember ifrs-full:RecurringFairValueMeasurementMember rdy:InvestmentInMarketLinkedDebenturesMember 2024-03-31 0001135951 ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:RecurringFairValueMeasurementMember rdy:InvestmentInMarketLinkedDebenturesMember 2024-03-31 0001135951 ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:RecurringFairValueMeasurementMember rdy:InvestmentInMarketLinkedDebenturesMember 2024-03-31 0001135951 ifrs-full:RecurringFairValueMeasurementMember rdy:InvestmentInMarketLinkedDebenturesMember 2024-03-31 0001135951 ifrs-full:RecurringFairValueMeasurementMember 2024-03-31 0001135951 ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:RecurringFairValueMeasurementMember 2024-03-31 0001135951 ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:RecurringFairValueMeasurementMember 2024-03-31 0001135951 ifrs-full:Level1OfFairValueHierarchyMember ifrs-full:RecurringFairValueMeasurementMember 2024-03-31 0001135951 rdy:RefundLiabilityMember 2024-03-31 0001135951 rdy:GlobalGenericsNorthAmericaOperationsMember 2024-03-31 0001135951 rdy:CategoryMember rdy:DrlTwoThousandSevenPlanMember 2024-03-31 0001135951 rdy:EquitySettledShareBasedPaymentExpenseMember 2024-03-31 0001135951 rdy:CashSettledSharebasedPaymentMember 2024-03-31 0001135951 rdy:DrlTwoThousandEighteenPlanMember 2024-03-31 0001135951 rdy:DrlTwoThousandEighteenPlanMember ifrs-full:BottomOfRangeMember 2024-03-31 0001135951 rdy:DrlTwoThousandEighteenPlanMember ifrs-full:TopOfRangeMember 2024-03-31 0001135951 rdy:CategoryMember rdy:DrlTwoThousandSevenPlanMember ifrs-full:BottomOfRangeMember 2024-03-31 0001135951 rdy:CategoryMember rdy:DrlTwoThousandSevenPlanMember ifrs-full:TopOfRangeMember 2024-03-31 0001135951 rdy:DrReddysEmployeesStockOptionScheme2018Member 2024-03-31 0001135951 ifrs-full:FactoringOfReceivablesMember 2024-03-31 0001135951 rdy:TermDepositsWithBanksAndBondsMember 2024-03-31 0001135951 rdy:WorkingsCapitalBorrowingsBrlMember 2024-03-31 0001135951 rdy:CurisIncMember 2024-03-31 0001135951 rdy:ProfitTaxImpactMember 2024-03-31 0001135951 ifrs-full:FinancialAssetsPastDueButNotImpairedMember 2024-03-31 0001135951 rdy:InvestmentInCompulsoryConvertibleDebenturesMember rdy:O2RenewableEnergyIxPrivateLimitedMember 2024-03-31 0001135951 rdy:InvestmentInCompulsoryConvertibleDebenturesMember 2024-03-31 0001135951 rdy:O2RenewableEnergyIxPrivateLimitedMember 2024-03-31 0001135951 rdy:ObligationsUnderLeasesMember 2024-03-31 0001135951 rdy:RouAssetTemporaryDifferencesMember 2024-03-31 0001135951 rdy:InventoryTemporaryDifferenceMember 2024-03-31 0001135951 ifrs-full:OtherTemporaryDifferencesMember 2024-03-31 0001135951 rdy:TaxAssetsLiabilitiesTemporaryDifferencesMember 2024-03-31 0001135951 rdy:LeaseLiabilitiesTemporaryDifferencesMember 2024-03-31 0001135951 rdy:PropertyPlantAndEquipmentTemporaryDifferenceMember 2024-03-31 0001135951 rdy:OtherIntangibleAssetsTemporaryDifferenceMember 2024-03-31 0001135951 rdy:OperatingAndOtherTaxLossCarryforwardMember 2024-03-31 0001135951 rdy:TradeAndOtherReceivablesTemporaryDifferenceMember 2024-03-31 0001135951 rdy:OtherCurrentAssetsAndOtherCurrentLiabilitiesNetTemporaryDifferenceMember 2024-03-31 0001135951 rdy:SetOffOfTaxesMemberTemporaryDifferencesMember 2024-03-31 0001135951 ifrs-full:Level1OfFairValueHierarchyMember ifrs-full:RecurringFairValueMeasurementMember ifrs-full:ContingentConsiderationMember 2024-03-31 0001135951 ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:RecurringFairValueMeasurementMember ifrs-full:ContingentConsiderationMember 2024-03-31 0001135951 ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:RecurringFairValueMeasurementMember ifrs-full:ContingentConsiderationMember 2024-03-31 0001135951 ifrs-full:RecurringFairValueMeasurementMember ifrs-full:ContingentConsiderationMember 2024-03-31 0001135951 rdy:CleanRenewableEnergyKK2APrivateLimitedMember 2024-03-31 0001135951 ifrs-full:OrdinarySharesMember 2025-03-31 0001135951 rdy:ParentCompanyGratuityPlanMember 2025-03-31 0001135951 rdy:BankOverdraftMember 2025-03-31 0001135951 rdy:OtherWorkingCapitalBorrowingsMember 2025-03-31 0001135951 rdy:PreshipmentCreditMember 2025-03-31 0001135951 ifrs-full:KeyManagementPersonnelOfEntityOrParentMember 2025-03-31 0001135951 rdy:KunshanRotamReddyPharmaceuticalsCompanyLimitedMember 2025-03-31 0001135951 rdy:DresEnergyPrivateLimitedMember 2025-03-31 0001135951 rdy:GreenParkHospitalityServicesPrivateLimitedMember 2025-03-31 0001135951 rdy:IndusProjectsPrivateLimitedMember 2025-03-31 0001135951 rdy:ZenfoldSustainableTechnologyPrivateLimitedMember 2025-03-31 0001135951 rdy:GreenParkHotelsAndResortsLimitedMember 2025-03-31 0001135951 rdy:StamloIndustriesLimitedMember 2025-03-31 0001135951 rdy:AssetTypeMember 2025-03-31 0001135951 rdy:KunshanRotamReddyPharmaceuticalsCoLimitedMember 2025-03-31 0001135951 rdy:LaterThanFourYearsMember 2025-03-31 0001135951 ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember 2025-03-31 0001135951 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember 2025-03-31 0001135951 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember 2025-03-31 0001135951 ifrs-full:NotLaterThanOneYearMember 2025-03-31 0001135951 rdy:FundsManagedByInsurersMember rdy:ParentCompanyGratuityPlanMember 2025-03-31 0001135951 rdy:IndiaCountryMember 2025-03-31 0001135951 rdy:SwitzerlandCountryMember 2025-03-31 0001135951 country:US 2025-03-31 0001135951 rdy:GermanyCountryMember 2025-03-31 0001135951 rdy:OtherCountriesMember 2025-03-31 0001135951 ifrs-full:OtherEnvironmentRelatedProvisionMember 2025-03-31 0001135951 rdy:NeitherPastDueMember ifrs-full:FinancialAssetsPastDueButNotImpairedMember 2025-03-31 0001135951 ifrs-full:FinancialAssetsImpairedMember ifrs-full:NotLaterThanOneYearMember 2025-03-31 0001135951 ifrs-full:FinancialAssetsImpairedMember ifrs-full:LaterThanOneYearMember 2025-03-31 0001135951 ifrs-full:FinancialAssetsPastDueButNotImpairedMember ifrs-full:LaterThanOneYearMember 2025-03-31 0001135951 ifrs-full:FinancialAssetsPastDueButNotImpairedMember ifrs-full:NotLaterThanOneYearMember 2025-03-31 0001135951 ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember rdy:GlobalGenericsBrandedFormulationsMember 2025-03-31 0001135951 ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember rdy:OtherCashgeneratingUnitsMember 2025-03-31 0001135951 ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember rdy:GlobalGenericsConsumerHealthcareBusinessMember 2025-03-31 0001135951 ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember 2025-03-31 0001135951 ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember rdy:PsaiActivePharmaceuticalOperationsMember 2025-03-31 0001135951 ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember rdy:GlobalGenericsComplexInjectablesMember 2025-03-31 0001135951 ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember rdy:GlobalGenericsNorthAmericaOperationsMember 2025-03-31 0001135951 ifrs-full:GrossCarryingAmountMember 2025-03-31 0001135951 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember 2025-03-31 0001135951 ifrs-full:LaterThanFiveYearsMember 2025-03-31 0001135951 rdy:GratuityBenefitsOfParentMember 2025-03-31 0001135951 rdy:NonderivativeFinancialInstrumentsMember rdy:UsDollarsMember 2025-03-31 0001135951 rdy:NonderivativeFinancialInstrumentsMember rdy:EurosMember 2025-03-31 0001135951 rdy:NonderivativeFinancialInstrumentsMember rdy:RussianRoublesMember 2025-03-31 0001135951 rdy:NonderivativeFinancialInstrumentsMember srt:OtherCurrencyMember 2025-03-31 0001135951 rdy:ForeignCurrencyRiskFromNonderivativeFinancialInstrumentsMember 2025-03-31 0001135951 rdy:NoncurrentAssetsMember 2025-03-31 0001135951 rdy:AurigenePharmaceuticalServicesLimitedMember 2025-03-31 0001135951 rdy:FiftyBasisPointsIncreaseMember rdy:ParentCompanyGratuityPlanMember rdy:SalaryGrowthMember 2025-03-31 0001135951 rdy:FiftyBasisPointsDecreaseMember rdy:ParentCompanyGratuityPlanMember rdy:SalaryGrowthMember 2025-03-31 0001135951 rdy:FiftyBasisPointsDecreaseMember rdy:ParentCompanyGratuityPlanMember rdy:DiscountRateMember 2025-03-31 0001135951 rdy:FiftyBasisPointsIncreaseMember rdy:ParentCompanyGratuityPlanMember rdy:DiscountRateMember 2025-03-31 0001135951 rdy:EmployeeBenefitObligationsMember rdy:ParentCompanyGratuityPlanMember 2025-03-31 0001135951 ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:RecurringFairValueMeasurementMember rdy:InvestmentInMfMember 2025-03-31 0001135951 ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:RecurringFairValueMeasurementMember rdy:InvestmentInMfMember 2025-03-31 0001135951 ifrs-full:Level1OfFairValueHierarchyMember ifrs-full:RecurringFairValueMeasurementMember rdy:InvestmentInLimitedLiabilityPartnershipFirmMember 2025-03-31 0001135951 ifrs-full:RecurringFairValueMeasurementMember rdy:InvestmentInOthersMember 2025-03-31 0001135951 ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:RecurringFairValueMeasurementMember rdy:InvestmentInEquityMember 2025-03-31 0001135951 ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:RecurringFairValueMeasurementMember rdy:InvestmentInLimitedLiabilityPartnershipFirmMember 2025-03-31 0001135951 ifrs-full:RecurringFairValueMeasurementMember rdy:InvestmentInEquityMember 2025-03-31 0001135951 ifrs-full:Level1OfFairValueHierarchyMember ifrs-full:RecurringFairValueMeasurementMember rdy:InvestmentInOthersMember 2025-03-31 0001135951 ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:RecurringFairValueMeasurementMember rdy:InvestmentInOthersMember 2025-03-31 0001135951 ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:RecurringFairValueMeasurementMember rdy:InvestmentInOthersMember 2025-03-31 0001135951 ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:RecurringFairValueMeasurementMember rdy:InvestmentInLimitedLiabilityPartnershipFirmMember 2025-03-31 0001135951 ifrs-full:RecurringFairValueMeasurementMember rdy:InvestmentInMfMember 2025-03-31 0001135951 ifrs-full:RecurringFairValueMeasurementMember rdy:InvestmentInLimitedLiabilityPartnershipFirmMember 2025-03-31 0001135951 ifrs-full:Level1OfFairValueHierarchyMember ifrs-full:RecurringFairValueMeasurementMember rdy:InvestmentInEquityMember 2025-03-31 0001135951 ifrs-full:Level1OfFairValueHierarchyMember ifrs-full:RecurringFairValueMeasurementMember rdy:InvestmentInMfMember 2025-03-31 0001135951 ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:RecurringFairValueMeasurementMember rdy:InvestmentInEquityMember 2025-03-31 0001135951 rdy:ComponentOfEquityBeforeTaxAdjustmentMember 2025-03-31 0001135951 rdy:EquitySettledShareBasedPaymentExpenseMember rdy:DrlTwoThousandEighteenPlanMember 2025-03-31 0001135951 rdy:CategoriesBMember rdy:Drl2007PlansMember 2025-03-31 0001135951 rdy:CategoriesAMember rdy:Drl2007PlansMember 2025-03-31 0001135951 rdy:InvestmentInCommercialPaperMember rdy:AtFairValueOrAmortizedCostMember 2025-03-31 0001135951 rdy:InvestmentInCommercialPaperMember rdy:AdjustmentOfRecognisedDirectlyInEquityMember 2025-03-31 0001135951 rdy:InvestmentInCommercialPaperMember ifrs-full:AtCostMember 2025-03-31 0001135951 rdy:BondMember rdy:AdjustmentOfRecognisedDirectlyInEquityMember 2025-03-31 0001135951 rdy:BondMember ifrs-full:AtCostMember 2025-03-31 0001135951 rdy:InvestmentInEquitySecuritiesMember ifrs-full:AtCostMember 2025-03-31 0001135951 rdy:OthersInvestmentMember rdy:AtFairValueOrAmortizedCostMember 2025-03-31 0001135951 rdy:OthersInvestmentMember rdy:AdjustmentOfRecognisedDirectlyInEquityMember 2025-03-31 0001135951 rdy:OthersInvestmentMember ifrs-full:AtCostMember 2025-03-31 0001135951 rdy:BondMember rdy:AtFairValueOrAmortizedCostMember 2025-03-31 0001135951 rdy:AtFairValueOrAmortizedCostMember ifrs-full:InvestmentFundsMember 2025-03-31 0001135951 rdy:AdjustmentOfRecognisedDirectlyInEquityMember ifrs-full:InvestmentFundsMember 2025-03-31 0001135951 ifrs-full:AtCostMember ifrs-full:InvestmentFundsMember 2025-03-31 0001135951 rdy:InvestmentInEquitySecuritiesMember rdy:AtFairValueOrAmortizedCostMember 2025-03-31 0001135951 rdy:InvestmentInEquitySecuritiesMember rdy:AdjustmentOfRecognisedDirectlyInEquityMember 2025-03-31 0001135951 rdy:TermDepositsWithBanksMember rdy:AtFairValueOrAmortizedCostMember 2025-03-31 0001135951 rdy:TermDepositsWithBanksMember rdy:AdjustmentOfRecognisedDirectlyInEquityMember 2025-03-31 0001135951 rdy:TermDepositsWithBanksMember ifrs-full:AtCostMember 2025-03-31 0001135951 rdy:AtFairValueOrAmortizedCostMember 2025-03-31 0001135951 rdy:AdjustmentOfRecognisedDirectlyInEquityMember 2025-03-31 0001135951 ifrs-full:AtCostMember 2025-03-31 0001135951 rdy:GlobalGenericsComplexInjectablesMember 2025-03-31 0001135951 rdy:InvestmentInLimitedLiabilityPartnershipMember rdy:AtFairValueOrAmortizedCostMember 2025-03-31 0001135951 rdy:InvestmentInLimitedLiabilityPartnershipMember rdy:AdjustmentOfRecognisedDirectlyInEquityMember 2025-03-31 0001135951 rdy:InvestmentInLimitedLiabilityPartnershipMember ifrs-full:AtCostMember 2025-03-31 0001135951 rdy:DepositsWithBanksAndFinancialInstitutionMember rdy:AtFairValueOrAmortizedCostMember 2025-03-31 0001135951 rdy:DepositsWithBanksAndFinancialInstitutionMember rdy:AdjustmentOfRecognisedDirectlyInEquityMember 2025-03-31 0001135951 rdy:DepositsWithBanksAndFinancialInstitutionMember ifrs-full:AtCostMember 2025-03-31 0001135951 rdy:TotalFairValueMember 2025-03-31 0001135951 rdy:ConsumerHealthcareBusinessMember 2025-03-31 0001135951 rdy:OtherCashgeneratingUnitsMember 2025-03-31 0001135951 rdy:AfterTaxMember rdy:ActivePharmaceuticalOperationsMember 2025-03-31 0001135951 rdy:BeforeTaxMember rdy:BrandedFormulationsMember 2025-03-31 0001135951 rdy:AfterTaxMember rdy:ComplexInjectablesAndNorthAmericaOperationsMember 2025-03-31 0001135951 rdy:BeforeTaxMember rdy:ComplexInjectablesAndNorthAmericaOperationsMember 2025-03-31 0001135951 rdy:AfterTaxMember rdy:ConsumerHealthcareBusinessMember 2025-03-31 0001135951 rdy:BeforeTaxMember rdy:ConsumerHealthcareBusinessMember 2025-03-31 0001135951 rdy:FuelSurchargeAdjustmentsMember 2025-03-31 0001135951 rdy:CardiovascularMember 2025-03-31 0001135951 rdy:CompensatedAbsencesMember 2025-03-31 0001135951 rdy:CategoryBParValueOptionsMember rdy:Drl2002PlanMember rdy:ExercisepricesRs5Member 2025-03-31 0001135951 rdy:CategoryBParValueOptionsMember rdy:DrlTwoThousandSevenPlanMember rdy:ExercisepricesRs5Member 2025-03-31 0001135951 rdy:CategoriesBMember rdy:Drl2002PlanMember 2025-03-31 0001135951 rdy:Drl2002PlanMember 2025-03-31 0001135951 rdy:CategoriesAMember rdy:Drl2002PlanMember 2025-03-31 0001135951 rdy:Drl2007PlansMember 2025-03-31 0001135951 rdy:ForwardContractCadInrSellMember rdy:ContractOneMember rdy:HedgesOfRecognisedAssetsAndLiabilitiesMember 2025-03-31 0001135951 rdy:OptionContractUsInrSellMember rdy:ContractTwentyMember rdy:HedgesOfHighlyProbableForecastedTransactionsMember 2025-03-31 0001135951 rdy:ForwardContractUsAudBuyMember rdy:ContractFourteenMember rdy:HedgesOfRecognisedAssetsAndLiabilitiesMember 2025-03-31 0001135951 rdy:ForwardContractUsRonBuyMember rdy:ContractFifteenMember rdy:HedgesOfRecognisedAssetsAndLiabilitiesMember 2025-03-31 0001135951 rdy:InterestRateSwapContractusInrsellMember rdy:ContractSixteenMember rdy:HedgesOfRecognisedAssetsAndLiabilitiesMember 2025-03-31 0001135951 rdy:ForwardContractUsInrSellMember rdy:ContractSeventeenMember rdy:HedgesOfHighlyProbableForecastedTransactionsMember 2025-03-31 0001135951 rdy:ForwardContractrubUssellMember rdy:ContractEighteenMember rdy:HedgesOfHighlyProbableForecastedTransactionsMember 2025-03-31 0001135951 rdy:ForwardContractUsBrlBuyMember rdy:ContractNineteenMember rdy:HedgesOfHighlyProbableForecastedTransactionsMember 2025-03-31 0001135951 rdy:ForwardContractUsClpBuyMember rdy:ContractEightMember rdy:HedgesOfRecognisedAssetsAndLiabilitiesMember 2025-03-31 0001135951 rdy:ForwardContractUsCopBuyMember rdy:ContractNineMember rdy:HedgesOfRecognisedAssetsAndLiabilitiesMember 2025-03-31 0001135951 rdy:ForwardContractUsKztBuyMember rdy:ContractTenMember rdy:HedgesOfRecognisedAssetsAndLiabilitiesMember 2025-03-31 0001135951 rdy:ForwardContractrubUssellMember rdy:ContractElevenMember rdy:HedgesOfRecognisedAssetsAndLiabilitiesMember 2025-03-31 0001135951 rdy:ForwardContractEurUsBuyMember rdy:ContractTwelveMember rdy:HedgesOfRecognisedAssetsAndLiabilitiesMember 2025-03-31 0001135951 rdy:ForwardContractGbpUsBuyMember rdy:ContractThirteenMember rdy:HedgesOfRecognisedAssetsAndLiabilitiesMember 2025-03-31 0001135951 rdy:ForwardContractUsInrSellMember rdy:ContractTwoMember rdy:HedgesOfRecognisedAssetsAndLiabilitiesMember 2025-03-31 0001135951 rdy:ForwardContractZarInrSellMember rdy:ContractThreeMember rdy:HedgesOfRecognisedAssetsAndLiabilitiesMember 2025-03-31 0001135951 rdy:ForwardContractGbpinrSellMember rdy:ContractFourMember rdy:HedgesOfRecognisedAssetsAndLiabilitiesMember 2025-03-31 0001135951 rdy:ForwardContractAudInrSellsMember rdy:ContractFiveMember rdy:HedgesOfRecognisedAssetsAndLiabilitiesMember 2025-03-31 0001135951 rdy:ForwardContractEurInrSellMember rdy:ContractSixMember rdy:HedgesOfRecognisedAssetsAndLiabilitiesMember 2025-03-31 0001135951 rdy:ForwardContractUsBrlBuyMember rdy:ContractSevenMember rdy:HedgesOfRecognisedAssetsAndLiabilitiesMember 2025-03-31 0001135951 rdy:UnutilizedCreditLimitsMember 2025-03-31 0001135951 ifrs-full:CashFlowHedgesMember 2025-03-31 0001135951 rdy:LoanFourMember ifrs-full:FloatingInterestRateMember 2025-03-31 0001135951 rdy:LoanFiveMember ifrs-full:FloatingInterestRateMember 2025-03-31 0001135951 rdy:LoanSixMember ifrs-full:FloatingInterestRateMember 2025-03-31 0001135951 rdy:LoanOneMember ifrs-full:FloatingInterestRateMember 2025-03-31 0001135951 rdy:LoanTwoMember ifrs-full:FloatingInterestRateMember 2025-03-31 0001135951 rdy:LoanThreeMember ifrs-full:FloatingInterestRateMember 2025-03-31 0001135951 rdy:HaleonUkEnterprisesLimitedMember 2025-03-31 0001135951 rdy:MaynePharmaGroupLimitedMember 2025-03-31 0001135951 rdy:ShanghaiHenliusBiotechzincMember 2025-03-31 0001135951 rdy:NovartisAGMember 2025-03-31 0001135951 rdy:UcbIndiaPrivateLimitedAndAffiliatesMember 2025-03-31 0001135951 rdy:WockhardtLimitedMember 2025-03-31 0001135951 rdy:InvestmentInUnquotedEquitySharesMember rdy:CleanRenewableEnergyKK2APrivateLimitedMember 2025-03-31 0001135951 rdy:InvestmentInUnquotedEquitySharesMember rdy:DresEnergyPrivateLimitedMember 2025-03-31 0001135951 rdy:InvestmentInUnquotedEquitySharesMember rdy:KunshanRotamReddyPharmaceuticalsCoLimitedMember 2025-03-31 0001135951 rdy:InvestmentInUnquotedEquitySharesMember 2025-03-31 0001135951 rdy:InvestmentInUnquotedEquitySharesMember rdy:O2RenewableEnergyIxPrivateLimitedMember 2025-03-31 0001135951 rdy:DresEnergyPrivateLimitedMember 2025-03-31 0001135951 ifrs-full:Level1OfFairValueHierarchyMember ifrs-full:RecurringFairValueMeasurementMember 2025-03-31 0001135951 ifrs-full:RecurringFairValueMeasurementMember 2025-03-31 0001135951 ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:RecurringFairValueMeasurementMember 2025-03-31 0001135951 ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:RecurringFairValueMeasurementMember 2025-03-31 0001135951 rdy:RefundLiabilityMember 2025-03-31 0001135951 rdy:GlobalGenericsNorthAmericaOperationsMember 2025-03-31 0001135951 rdy:CategoryMember rdy:DrlTwoThousandSevenPlanMember 2025-03-31 0001135951 rdy:EquitySettledShareBasedPaymentExpenseMember 2025-03-31 0001135951 rdy:CashSettledSharebasedPaymentMember 2025-03-31 0001135951 rdy:DrlTwoThousandEighteenPlanMember 2025-03-31 0001135951 rdy:DrlTwoThousandEighteenPlanMember ifrs-full:BottomOfRangeMember 2025-03-31 0001135951 rdy:DrlTwoThousandEighteenPlanMember ifrs-full:TopOfRangeMember 2025-03-31 0001135951 ifrs-full:LegalProceedingsProvisionMember 2025-03-31 0001135951 ifrs-full:RefundsProvisionMember 2025-03-31 0001135951 rdy:ParentCompanyGratuityPlanMember rdy:Year4Member 2025-03-31 0001135951 rdy:ParentCompanyGratuityPlanMember rdy:AfterYear5Member 2025-03-31 0001135951 rdy:ParentCompanyGratuityPlanMember rdy:Year3Member 2025-03-31 0001135951 rdy:ParentCompanyGratuityPlanMember rdy:Year2Member 2025-03-31 0001135951 rdy:ParentCompanyGratuityPlanMember rdy:Year1Member 2025-03-31 0001135951 rdy:DrReddysEmployeesStockOptionScheme2007Member 2025-03-31 0001135951 rdy:PriorToStockSplitDrReddysEmployeesStockOptionScheme2018Member 2025-03-31 0001135951 rdy:CategoryMember rdy:DrlTwoThousandSevenPlanMember ifrs-full:BottomOfRangeMember 2025-03-31 0001135951 rdy:CategoryMember rdy:DrlTwoThousandSevenPlanMember ifrs-full:TopOfRangeMember 2025-03-31 0001135951 rdy:DrReddysEmployeesStockOptionScheme2018Member 2025-03-31 0001135951 ifrs-full:FactoringOfReceivablesMember 2025-03-31 0001135951 rdy:TermDepositsWithBanksAndBondsMember 2025-03-31 0001135951 rdy:WorkingsCapitalBorrowingssInrMember 2025-03-31 0001135951 rdy:CurisIncMember 2025-03-31 0001135951 rdy:ProfitTaxImpactMember 2025-03-31 0001135951 ifrs-full:FinancialAssetsPastDueButNotImpairedMember 2025-03-31 0001135951 rdy:InvestmentInCompulsoryConvertibleDebenturesMember rdy:O2RenewableEnergyIxPrivateLimitedMember 2025-03-31 0001135951 rdy:InvestmentInCompulsoryConvertibleDebenturesMember 2025-03-31 0001135951 rdy:O2RenewableEnergyIxPrivateLimitedMember 2025-03-31 0001135951 rdy:ObligationsUnderLeasesMember 2025-03-31 0001135951 rdy:RouAssetTemporaryDifferencesMember 2025-03-31 0001135951 rdy:InventoryTemporaryDifferenceMember 2025-03-31 0001135951 ifrs-full:OtherTemporaryDifferencesMember 2025-03-31 0001135951 rdy:TaxAssetsLiabilitiesTemporaryDifferencesMember 2025-03-31 0001135951 rdy:LeaseLiabilitiesTemporaryDifferencesMember 2025-03-31 0001135951 rdy:PropertyPlantAndEquipmentTemporaryDifferenceMember 2025-03-31 0001135951 rdy:OtherIntangibleAssetsTemporaryDifferenceMember 2025-03-31 0001135951 rdy:OperatingAndOtherTaxLossCarryforwardMember 2025-03-31 0001135951 rdy:OtherCurrentAssetsAndOtherCurrentLiabilitiesNetTemporaryDifferenceMember 2025-03-31 0001135951 rdy:TradeAndOtherReceivablesTemporaryDifferenceMember 2025-03-31 0001135951 rdy:SetOffOfTaxesMemberTemporaryDifferencesMember 2025-03-31 0001135951 ifrs-full:Level1OfFairValueHierarchyMember ifrs-full:RecurringFairValueMeasurementMember ifrs-full:ContingentConsiderationMember 2025-03-31 0001135951 ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:RecurringFairValueMeasurementMember ifrs-full:ContingentConsiderationMember 2025-03-31 0001135951 ifrs-full:RecurringFairValueMeasurementMember ifrs-full:ContingentConsiderationMember 2025-03-31 0001135951 ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:RecurringFairValueMeasurementMember ifrs-full:ContingentConsiderationMember 2025-03-31 0001135951 rdy:NestleIndiaMember 2025-03-31 0001135951 rdy:HaleonMember 2025-03-31 0001135951 rdy:NestleIndiaMember rdy:NutraceuticalsSubsidiaryMember 2025-03-31 0001135951 rdy:NrtMember rdy:HaleonMember rdy:NorthstarSwitzerlandSarlMember 2025-03-31 0001135951 rdy:HaleonMember rdy:NorthstarSwitzerlandSarlMember rdy:SalesTarget2024Member 2025-03-31 0001135951 rdy:CleanRenewableEnergyKK2APrivateLimitedMember 2025-03-31 0001135951 ifrs-full:DerivativesMember 2022-04-01 2023-03-31 0001135951 rdy:KeyManagementPersonnelMember 2022-04-01 2023-03-31 0001135951 ifrs-full:OrdinarySharesMember 2022-04-01 2023-03-31 0001135951 rdy:EquitySharedPaymentSettledMember 2022-04-01 2023-03-31 0001135951 rdy:SellingGeneralAndAdministrativeExpensesOneMember 2022-04-01 2023-03-31 0001135951 rdy:ResearchAndDevelopmentExpensesMember 2022-04-01 2023-03-31 0001135951 rdy:CostOfRevenuesMember 2022-04-01 2023-03-31 0001135951 ifrs-full:CountryOfDomicileMember 2022-04-01 2023-03-31 0001135951 ifrs-full:ForeignCountriesMember 2022-04-01 2023-03-31 0001135951 rdy:CashSettledSharebasedPaymentMember 2022-04-01 2023-03-31 0001135951 rdy:ParentCompanyGratuityPlanMember 2022-04-01 2023-03-31 0001135951 rdy:KunshanRotamReddyPharmaceuticalsCoLimitedMember 2022-04-01 2023-03-31 0001135951 rdy:PharmaceuticalServicesAndActiveIngredientsMember 2022-04-01 2023-03-31 0001135951 rdy:OtherSegmentMember 2022-04-01 2023-03-31 0001135951 rdy:GlobalGenericsMember 2022-04-01 2023-03-31 0001135951 rdy:OthersCountriesCountryMember 2022-04-01 2023-03-31 0001135951 rdy:RussiaCountryMember 2022-04-01 2023-03-31 0001135951 rdy:IndiaCountryMember 2022-04-01 2023-03-31 0001135951 country:US 2022-04-01 2023-03-31 0001135951 rdy:OthersSegmentsMember rdy:CostOfRevenuesMember 2022-04-01 2023-03-31 0001135951 rdy:GlobalGenericMember rdy:CostOfRevenuesMember 2022-04-01 2023-03-31 0001135951 rdy:PharmaceuticalServicesAndActiveIngredientMember rdy:CostOfRevenuesMember 2022-04-01 2023-03-31 0001135951 rdy:GlobalGenericMember 2022-04-01 2023-03-31 0001135951 rdy:OtherGlobalGenericsMember rdy:GlobalGenericMember 2022-04-01 2023-03-31 0001135951 rdy:CentralNervousSystemMember rdy:GlobalGenericMember 2022-04-01 2023-03-31 0001135951 rdy:OncologyMember rdy:GlobalGenericMember 2022-04-01 2023-03-31 0001135951 rdy:GastrointestinalMember rdy:GlobalGenericMember 2022-04-01 2023-03-31 0001135951 rdy:PainManagementMember rdy:GlobalGenericMember 2022-04-01 2023-03-31 0001135951 rdy:AntiinfectiveMember rdy:GlobalGenericMember 2022-04-01 2023-03-31 0001135951 rdy:RespiratoryMember rdy:GlobalGenericMember 2022-04-01 2023-03-31 0001135951 rdy:NutraceuticalMember rdy:GlobalGenericMember 2022-04-01 2023-03-31 0001135951 rdy:DiabetologyMember rdy:GlobalGenericMember 2022-04-01 2023-03-31 0001135951 rdy:DermatologyMember rdy:GlobalGenericMember 2022-04-01 2023-03-31 0001135951 rdy:HematologyMember rdy:GlobalGenericMember 2022-04-01 2023-03-31 0001135951 rdy:CardiovascularMember rdy:GlobalGenericMember 2022-04-01 2023-03-31 0001135951 rdy:GenitourinaryMember rdy:PharmaceuticalServicesAndActiveIngredientMember 2022-04-01 2023-03-31 0001135951 rdy:DermatologyMember rdy:PharmaceuticalServicesAndActiveIngredientMember 2022-04-01 2023-03-31 0001135951 rdy:GastrointestinalMember rdy:PharmaceuticalServicesAndActiveIngredientMember 2022-04-01 2023-03-31 0001135951 rdy:DiabetologyMember rdy:PharmaceuticalServicesAndActiveIngredientMember 2022-04-01 2023-03-31 0001135951 rdy:PainManagementMember rdy:PharmaceuticalServicesAndActiveIngredientMember 2022-04-01 2023-03-31 0001135951 rdy:AntiInfectiveOneMember rdy:PharmaceuticalServicesAndActiveIngredientMember 2022-04-01 2023-03-31 0001135951 rdy:HematologyMember rdy:PharmaceuticalServicesAndActiveIngredientMember 2022-04-01 2023-03-31 0001135951 rdy:PharmaceuticalServicesAndActiveIngredientMember 2022-04-01 2023-03-31 0001135951 rdy:OtherPsaiMember rdy:PharmaceuticalServicesAndActiveIngredientMember 2022-04-01 2023-03-31 0001135951 rdy:RespiratoryMember rdy:PharmaceuticalServicesAndActiveIngredientMember 2022-04-01 2023-03-31 0001135951 rdy:CentralNervousSystemMember rdy:PharmaceuticalServicesAndActiveIngredientMember 2022-04-01 2023-03-31 0001135951 rdy:CardiovascularMember rdy:PharmaceuticalServicesAndActiveIngredientMember 2022-04-01 2023-03-31 0001135951 rdy:OncologyMember rdy:PharmaceuticalServicesAndActiveIngredientMember 2022-04-01 2023-03-31 0001135951 ifrs-full:RetainedEarningsMember 2022-04-01 2023-03-31 0001135951 ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember 2022-04-01 2023-03-31 0001135951 rdy:FairValueReserveMember 2022-04-01 2023-03-31 0001135951 ifrs-full:ReserveOfSharebasedPaymentsMember 2022-04-01 2023-03-31 0001135951 ifrs-full:TreasurySharesMember 2022-04-01 2023-03-31 0001135951 ifrs-full:SharePremiumMember 2022-04-01 2023-03-31 0001135951 ifrs-full:IssuedCapitalMember 2022-04-01 2023-03-31 0001135951 ifrs-full:ReserveOfCashFlowHedgesMember 2022-04-01 2023-03-31 0001135951 rdy:SpecialEconomicZoneReinvestmentReserveMember 2022-04-01 2023-03-31 0001135951 rdy:ActuarialGainsLossesMember 2022-04-01 2023-03-31 0001135951 ifrs-full:CapitalRedemptionReserveMember 2022-04-01 2023-03-31 0001135951 rdy:DebentureRedemptionReserveMember 2022-04-01 2023-03-31 0001135951 ifrs-full:InterestRateSwapContractMember 2022-04-01 2023-03-31 0001135951 rdy:ProvidentFundBenefitsMember 2022-04-01 2023-03-31 0001135951 rdy:SuperannuationBenefitsMember 2022-04-01 2023-03-31 0001135951 rdy:Us401kretirementSavingsPlanMember 2022-04-01 2023-03-31 0001135951 rdy:UkSocialSecuriyPlanMember 2022-04-01 2023-03-31 0001135951 rdy:DresEnergyPrivateLimitedMember 2022-04-01 2023-03-31 0001135951 rdy:RebatesMember 2022-04-01 2023-03-31 0001135951 rdy:ChargebacksMember 2022-04-01 2023-03-31 0001135951 rdy:MedicaidMember 2022-04-01 2023-03-31 0001135951 rdy:RefundLiabilityMember 2022-04-01 2023-03-31 0001135951 rdy:JbChemicalsAndPharmaceuticalsLimitedMember 2022-04-01 2023-03-31 0001135951 rdy:TorrentPharmaceuticalsLimitedMember 2022-04-01 2023-03-31 0001135951 rdy:ErisLifesciencesLimitedMember 2022-04-01 2023-03-31 0001135951 rdy:SettlementAgreementMember rdy:IndiviorIncIndiviorUkLimitedAndaquestivetherapeuticsIncMember rdy:ProprietaryProductsMember 2022-04-01 2023-03-31 0001135951 rdy:DelpharmDevelopmentLeidenBvMember 2022-04-01 2023-03-31 0001135951 rdy:DrReddysEmployeesStockOptionScheme2018Member 2022-04-01 2023-03-31 0001135951 rdy:AfterStockSplitDrReddysEmployeesStockOptionScheme2018Member 2022-04-01 2023-03-31 0001135951 rdy:O2RenewableEnergyIxPrivateLimitedMember 2022-04-01 2023-03-31 0001135951 rdy:CleanRenewableEnergyKK2APrivateLimitedMember 2022-04-01 2023-03-31 0001135951 ifrs-full:DerivativesMember 2023-04-01 2024-03-31 0001135951 rdy:KeyManagementPersonnelMember 2023-04-01 2024-03-31 0001135951 ifrs-full:IntangibleAssetsUnderDevelopmentMember 2023-04-01 2024-03-31 0001135951 ifrs-full:OrdinarySharesMember 2023-04-01 2024-03-31 0001135951 rdy:EquitySharedPaymentSettledMember 2023-04-01 2024-03-31 0001135951 rdy:ResearchAndDevelopmentExpensesMember 2023-04-01 2024-03-31 0001135951 rdy:SellingGeneralAndAdministrativeExpensesOneMember 2023-04-01 2024-03-31 0001135951 rdy:CostOfRevenuesMember 2023-04-01 2024-03-31 0001135951 ifrs-full:CountryOfDomicileMember 2023-04-01 2024-03-31 0001135951 ifrs-full:ForeignCountriesMember 2023-04-01 2024-03-31 0001135951 rdy:CashSettledSharebasedPaymentMember 2023-04-01 2024-03-31 0001135951 rdy:ParentCompanyGratuityPlanMember 2023-04-01 2024-03-31 0001135951 rdy:KunshanRotamReddyPharmaceuticalsCoLimitedMember 2023-04-01 2024-03-31 0001135951 currency:USD 2023-04-01 2024-03-31 0001135951 rdy:OtherCountriesMember 2023-04-01 2024-03-31 0001135951 rdy:IndiaCountryMember 2023-04-01 2024-03-31 0001135951 rdy:SwitzerlandCountryMember 2023-04-01 2024-03-31 0001135951 rdy:PharmaceuticalServicesAndActiveIngredientsMember 2023-04-01 2024-03-31 0001135951 rdy:OtherSegmentMember 2023-04-01 2024-03-31 0001135951 rdy:GlobalGenericsMember 2023-04-01 2024-03-31 0001135951 rdy:OthersCountriesCountryMember 2023-04-01 2024-03-31 0001135951 rdy:RussiaCountryMember 2023-04-01 2024-03-31 0001135951 country:US 2023-04-01 2024-03-31 0001135951 rdy:GratuityBenefitsOfParentMember 2023-04-01 2024-03-31 0001135951 ifrs-full:LongtermBorrowingsMember 2023-04-01 2024-03-31 0001135951 ifrs-full:ShorttermBorrowingsMember 2023-04-01 2024-03-31 0001135951 rdy:WorkingsCapitalBorrowingsRubMember 2023-04-01 2024-03-31 0001135951 rdy:WorkingCapitalBorrowingsMxnMember 2023-04-01 2024-03-31 0001135951 rdy:WorkingsCapitalBorrowingssInrMember 2023-04-01 2024-03-31 0001135951 rdy:WorkingsCapitalBorrowingsBrlMember 2023-04-01 2024-03-31 0001135951 rdy:PackingCreditBorrowingsInrMember 2023-04-01 2024-03-31 0001135951 ifrs-full:NotLaterThanOneMonthMember rdy:BrazilianRealsMember 2023-04-01 2024-03-31 0001135951 ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember rdy:BrazilianRealsMember 2023-04-01 2024-03-31 0001135951 ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember rdy:BrazilianRealsMember 2023-04-01 2024-03-31 0001135951 ifrs-full:LaterThanSixMonthsAndNotLaterThanOneYearMember rdy:BrazilianRealsMember 2023-04-01 2024-03-31 0001135951 rdy:UsDollarsMember 2023-04-01 2024-03-31 0001135951 ifrs-full:LaterThanSixMonthsAndNotLaterThanOneYearMember rdy:RussianRoublesMember 2023-04-01 2024-03-31 0001135951 rdy:BrazilianRealsMember 2023-04-01 2024-03-31 0001135951 ifrs-full:NotLaterThanOneMonthMember rdy:UsDollarsMember 2023-04-01 2024-03-31 0001135951 ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember rdy:RussianRoublesMember 2023-04-01 2024-03-31 0001135951 ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember rdy:RussianRoublesMember 2023-04-01 2024-03-31 0001135951 ifrs-full:LaterThanSixMonthsAndNotLaterThanOneYearMember rdy:UsDollarsMember 2023-04-01 2024-03-31 0001135951 ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember rdy:UsDollarsMember 2023-04-01 2024-03-31 0001135951 ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember rdy:UsDollarsMember 2023-04-01 2024-03-31 0001135951 ifrs-full:NotLaterThanOneMonthMember rdy:RussianRoublesMember 2023-04-01 2024-03-31 0001135951 rdy:RussianRoublesMember 2023-04-01 2024-03-31 0001135951 ifrs-full:OrdinarySharesMember 2023-04-01 2024-03-31 0001135951 rdy:OperatingAndOtherTaxLossCarryforwardMember 2023-04-01 2024-03-31 0001135951 rdy:InventorydeferredTaxLiabilityAssetMember 2023-04-01 2024-03-31 0001135951 rdy:OtherCurrentAssetsAndOtherCurrentLiabilitiesNetdeferredTaxLiabilityAssetMember 2023-04-01 2024-03-31 0001135951 rdy:PropertyPlantAndEquipmentdeferredTaxLiabilityAssetMember 2023-04-01 2024-03-31 0001135951 rdy:OthersdeferredTaxLiabilityAssetMember 2023-04-01 2024-03-31 0001135951 rdy:IntangibleAssetsdeferredTaxLiabilityAssetMember 2023-04-01 2024-03-31 0001135951 rdy:TradeAndOtherReceivablesdeferredTaxLiabilityAssetMember 2023-04-01 2024-03-31 0001135951 rdy:LeaseLiabilitiesTemporaryDifferencesMember 2023-04-01 2024-03-31 0001135951 rdy:RouAssetTemporaryDifferencesMember 2023-04-01 2024-03-31 0001135951 rdy:OthersSegmentsMember rdy:CostOfRevenuesMember 2023-04-01 2024-03-31 0001135951 rdy:GlobalGenericMember rdy:CostOfRevenuesMember 2023-04-01 2024-03-31 0001135951 rdy:PharmaceuticalServicesAndActiveIngredientMember rdy:CostOfRevenuesMember 2023-04-01 2024-03-31 0001135951 rdy:OncologyMember rdy:GlobalGenericMember 2023-04-01 2024-03-31 0001135951 rdy:OtherGlobalGenericsMember rdy:GlobalGenericMember 2023-04-01 2024-03-31 0001135951 rdy:PainManagementMember rdy:GlobalGenericMember 2023-04-01 2024-03-31 0001135951 rdy:CentralNervousSystemMember rdy:GlobalGenericMember 2023-04-01 2024-03-31 0001135951 rdy:RespiratoryMember rdy:GlobalGenericMember 2023-04-01 2024-03-31 0001135951 rdy:GastrointestinalMember rdy:GlobalGenericMember 2023-04-01 2024-03-31 0001135951 rdy:CardiovascularMember rdy:GlobalGenericMember 2023-04-01 2024-03-31 0001135951 rdy:AntiinfectiveMember rdy:GlobalGenericMember 2023-04-01 2024-03-31 0001135951 rdy:GlobalGenericMember 2023-04-01 2024-03-31 0001135951 rdy:DiabetologyMember rdy:GlobalGenericMember 2023-04-01 2024-03-31 0001135951 rdy:NutraceuticalMember rdy:GlobalGenericMember 2023-04-01 2024-03-31 0001135951 rdy:DermatologyMember rdy:GlobalGenericMember 2023-04-01 2024-03-31 0001135951 rdy:HematologyMember rdy:GlobalGenericMember 2023-04-01 2024-03-31 0001135951 rdy:GenitourinaryMember rdy:PharmaceuticalServicesAndActiveIngredientMember 2023-04-01 2024-03-31 0001135951 rdy:DermatologyMember rdy:PharmaceuticalServicesAndActiveIngredientMember 2023-04-01 2024-03-31 0001135951 rdy:DiabetologyMember rdy:PharmaceuticalServicesAndActiveIngredientMember 2023-04-01 2024-03-31 0001135951 rdy:RespiratoryMember rdy:PharmaceuticalServicesAndActiveIngredientMember 2023-04-01 2024-03-31 0001135951 rdy:AntiInfectiveOneMember rdy:PharmaceuticalServicesAndActiveIngredientMember 2023-04-01 2024-03-31 0001135951 rdy:GastrointestinalMember rdy:PharmaceuticalServicesAndActiveIngredientMember 2023-04-01 2024-03-31 0001135951 rdy:HematologyMember rdy:PharmaceuticalServicesAndActiveIngredientMember 2023-04-01 2024-03-31 0001135951 rdy:CentralNervousSystemMember rdy:PharmaceuticalServicesAndActiveIngredientMember 2023-04-01 2024-03-31 0001135951 rdy:PainManagementMember rdy:PharmaceuticalServicesAndActiveIngredientMember 2023-04-01 2024-03-31 0001135951 rdy:PharmaceuticalServicesAndActiveIngredientMember 2023-04-01 2024-03-31 0001135951 rdy:OtherPsaiMember rdy:PharmaceuticalServicesAndActiveIngredientMember 2023-04-01 2024-03-31 0001135951 rdy:CardiovascularMember rdy:PharmaceuticalServicesAndActiveIngredientMember 2023-04-01 2024-03-31 0001135951 rdy:OncologyMember rdy:PharmaceuticalServicesAndActiveIngredientMember 2023-04-01 2024-03-31 0001135951 ifrs-full:GrossCarryingAmountMember 2023-04-01 2024-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:OtherIntangibleAssetsMember 2023-04-01 2024-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2023-04-01 2024-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:RecipesFormulaeModelsDesignsAndPrototypesMember 2023-04-01 2024-03-31 0001135951 ifrs-full:ClassesOfPropertyPlantAndEquipmentDomain 2023-04-01 2024-03-31 0001135951 ifrs-full:ReserveOfCashFlowHedgesMember 2023-04-01 2024-03-31 0001135951 ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember 2023-04-01 2024-03-31 0001135951 rdy:FairValueReserveMember 2023-04-01 2024-03-31 0001135951 ifrs-full:ReserveOfSharebasedPaymentsMember 2023-04-01 2024-03-31 0001135951 ifrs-full:TreasurySharesMember 2023-04-01 2024-03-31 0001135951 ifrs-full:SharePremiumMember 2023-04-01 2024-03-31 0001135951 ifrs-full:IssuedCapitalMember 2023-04-01 2024-03-31 0001135951 rdy:ActuarialGainsLossesMember 2023-04-01 2024-03-31 0001135951 rdy:DebentureRedemptionReserveMember 2023-04-01 2024-03-31 0001135951 rdy:SpecialEconomicZoneReinvestmentReserveMember 2023-04-01 2024-03-31 0001135951 ifrs-full:CapitalRedemptionReserveMember 2023-04-01 2024-03-31 0001135951 ifrs-full:RetainedEarningsMember 2023-04-01 2024-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember 2023-04-01 2024-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember ifrs-full:OtherIntangibleAssetsMember 2023-04-01 2024-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2023-04-01 2024-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember ifrs-full:RecipesFormulaeModelsDesignsAndPrototypesMember 2023-04-01 2024-03-31 0001135951 ifrs-full:InterestRateSwapContractMember 2023-04-01 2024-03-31 0001135951 rdy:ProvidentFundBenefitsMember 2023-04-01 2024-03-31 0001135951 rdy:SuperannuationBenefitsMember 2023-04-01 2024-03-31 0001135951 rdy:UkSocialSecuriyPlanMember 2023-04-01 2024-03-31 0001135951 rdy:Us401kretirementSavingsPlanMember 2023-04-01 2024-03-31 0001135951 rdy:CategoryBParValueOptionsMember rdy:DrlTwoThousandSevenPlanMember rdy:ExercisepricesRs5Member 2023-04-01 2024-03-31 0001135951 rdy:CategoryBParValueOptionsMember rdy:Drl2002PlanMember rdy:ExercisepricesRs5Member 2023-04-01 2024-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:LandMember 2023-04-01 2024-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:BuildingsMember 2023-04-01 2024-03-31 0001135951 ifrs-full:GrossCarryingAmountMember rdy:PlantAndEquipmentMember 2023-04-01 2024-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:OfficeEquipmentMember 2023-04-01 2024-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:VehiclesMember 2023-04-01 2024-03-31 0001135951 rdy:CategoriesBMember rdy:Drl2007PlansMember 2023-04-01 2024-03-31 0001135951 rdy:CategoriesAMember rdy:Drl2007PlansMember 2023-04-01 2024-03-31 0001135951 rdy:EquitySettledShareBasedPaymentExpenseMember rdy:DrlTwoThousandEighteenPlanMember 2023-04-01 2024-03-31 0001135951 rdy:Drl2002PlanMember 2023-04-01 2024-03-31 0001135951 rdy:EquitySettledShareBasedPaymentExpenseMember 2023-04-01 2024-03-31 0001135951 rdy:CashSettledSharebasedPaymentMember 2023-04-01 2024-03-31 0001135951 rdy:LoanThreeMember ifrs-full:FloatingInterestRateMember 2023-04-01 2024-03-31 0001135951 rdy:LoanTwoMember ifrs-full:FloatingInterestRateMember 2023-04-01 2024-03-31 0001135951 rdy:LoanOneMember ifrs-full:FloatingInterestRateMember 2023-04-01 2024-03-31 0001135951 rdy:DresEnergyPrivateLimitedMember 2023-04-01 2024-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember ifrs-full:VehiclesMember 2023-04-01 2024-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember ifrs-full:LandMember 2023-04-01 2024-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember ifrs-full:BuildingsMember 2023-04-01 2024-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember rdy:PlantAndEquipmentMember 2023-04-01 2024-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember ifrs-full:OfficeEquipmentMember 2023-04-01 2024-03-31 0001135951 rdy:SaxagliptinMember 2023-04-01 2024-03-31 0001135951 rdy:OtherSegmentsMember 2023-04-01 2024-03-31 0001135951 rdy:Product1RelatedIntangiblesMember rdy:GlobalGenericMember 2023-04-01 2024-03-31 0001135951 rdy:Product2RelatedIntangiblesMember rdy:GlobalGenericMember 2023-04-01 2024-03-31 0001135951 rdy:ChargebacksMember 2023-04-01 2024-03-31 0001135951 rdy:RefundLiabilityMember 2023-04-01 2024-03-31 0001135951 rdy:MedicaidMember 2023-04-01 2024-03-31 0001135951 rdy:RebatesMember 2023-04-01 2024-03-31 0001135951 rdy:CategoryMember rdy:DrlTwoThousandSevenPlanMember 2023-04-01 2024-03-31 0001135951 rdy:CategoryMember rdy:DrlTwoThousandSevenPlanMember ifrs-full:BottomOfRangeMember 2023-04-01 2024-03-31 0001135951 rdy:CategoryMember rdy:DrlTwoThousandSevenPlanMember ifrs-full:TopOfRangeMember 2023-04-01 2024-03-31 0001135951 rdy:DrlTwoThousandEighteenPlanMember 2023-04-01 2024-03-31 0001135951 rdy:DrlTwoThousandEighteenPlanMember ifrs-full:BottomOfRangeMember 2023-04-01 2024-03-31 0001135951 rdy:DrlTwoThousandEighteenPlanMember ifrs-full:TopOfRangeMember 2023-04-01 2024-03-31 0001135951 rdy:SettlementAgreementMember 2023-04-01 2024-03-31 0001135951 rdy:AccumulatedDepreciationMember ifrs-full:VehiclesMember 2023-04-01 2024-03-31 0001135951 rdy:AccumulatedDepreciationMember rdy:PlantAndEquipmentMember 2023-04-01 2024-03-31 0001135951 rdy:AccumulatedDepreciationMember ifrs-full:BuildingsMember 2023-04-01 2024-03-31 0001135951 rdy:AccumulatedDepreciationMember ifrs-full:LandMember 2023-04-01 2024-03-31 0001135951 rdy:AccumulatedDepreciationMember rdy:FurnitureFixturesAndOfficeEquipmentMember 2023-04-01 2024-03-31 0001135951 rdy:AccumulatedDepreciationMember 2023-04-01 2024-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:BuildingsMember 2023-04-01 2024-03-31 0001135951 ifrs-full:GrossCarryingAmountMember rdy:FurnitureFixturesAndOfficeEquipmentMember 2023-04-01 2024-03-31 0001135951 ifrs-full:GrossCarryingAmountMember rdy:PlantAndEquipmentMember 2023-04-01 2024-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:LandMember 2023-04-01 2024-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:VehiclesMember 2023-04-01 2024-03-31 0001135951 rdy:DrReddysEmployeesStockOptionScheme2007Member 2023-04-01 2024-03-31 0001135951 rdy:DrReddysEmployeesStockOptionScheme2018Member 2023-04-01 2024-03-31 0001135951 rdy:AfterStockSplitDrReddysEmployeesStockOptionScheme2018Member 2023-04-01 2024-03-31 0001135951 rdy:WockhardtLimitedMember 2023-04-01 2024-03-31 0001135951 rdy:TermLoanFromBankMember currency:INR 2023-04-01 2024-03-31 0001135951 rdy:ToripalimabMember 2023-04-01 2024-03-31 0001135951 rdy:GenericPrescriptionProductsPortfolioMember 2023-04-01 2024-03-31 0001135951 rdy:O2RenewableEnergyIxPrivateLimitedMember 2023-04-01 2024-03-31 0001135951 rdy:TransitionalDistributionServicesAgreementMember rdy:HaleonMember 2023-04-01 2024-03-31 0001135951 rdy:TransitionalDistributionServicesAgreementMember ifrs-full:SellingGeneralAndAdministrativeExpenseMember rdy:HaleonMember 2023-04-01 2024-03-31 0001135951 rdy:CleanRenewableEnergyKK2APrivateLimitedMember 2023-04-01 2024-03-31 0001135951 ifrs-full:DerivativesMember 2024-04-01 2025-03-31 0001135951 ifrs-full:ReportableSegmentsMember 2024-04-01 2025-03-31 0001135951 rdy:KunshanRotamReddyPharmaceuticalsCoLimitedMember 2024-04-01 2025-03-31 0001135951 rdy:KeyManagementPersonnelMember 2024-04-01 2025-03-31 0001135951 ifrs-full:IntangibleAssetsUnderDevelopmentMember 2024-04-01 2025-03-31 0001135951 ifrs-full:OrdinarySharesMember 2024-04-01 2025-03-31 0001135951 rdy:EquitySharedPaymentSettledMember 2024-04-01 2025-03-31 0001135951 rdy:ResearchAndDevelopmentExpensesMember 2024-04-01 2025-03-31 0001135951 rdy:CostOfRevenuesMember 2024-04-01 2025-03-31 0001135951 rdy:SellingGeneralAndAdministrativeExpensesOneMember 2024-04-01 2025-03-31 0001135951 ifrs-full:CountryOfDomicileMember 2024-04-01 2025-03-31 0001135951 ifrs-full:ForeignCountriesMember 2024-04-01 2025-03-31 0001135951 rdy:CashSettledSharebasedPaymentMember 2024-04-01 2025-03-31 0001135951 rdy:ParentCompanyGratuityPlanMember 2024-04-01 2025-03-31 0001135951 rdy:KunshanRotamReddyPharmaceuticalsCoLimitedMember 2024-04-01 2025-03-31 0001135951 rdy:OtherCountriesMember 2024-04-01 2025-03-31 0001135951 rdy:IndiaCountryMember 2024-04-01 2025-03-31 0001135951 rdy:SwitzerlandCountryMember 2024-04-01 2025-03-31 0001135951 currency:USD 2024-04-01 2025-03-31 0001135951 rdy:GlobalGenericsMember 2024-04-01 2025-03-31 0001135951 rdy:OtherSegmentMember 2024-04-01 2025-03-31 0001135951 rdy:PharmaceuticalServicesAndActiveIngredientsMember 2024-04-01 2025-03-31 0001135951 rdy:OthersCountriesCountryMember 2024-04-01 2025-03-31 0001135951 rdy:RussiaCountryMember 2024-04-01 2025-03-31 0001135951 country:US 2024-04-01 2025-03-31 0001135951 rdy:GratuityBenefitsOfParentMember 2024-04-01 2025-03-31 0001135951 ifrs-full:LegalProceedingsProvisionMember 2024-04-01 2025-03-31 0001135951 ifrs-full:RefundsProvisionMember 2024-04-01 2025-03-31 0001135951 rdy:Drl2002PlanMember 2024-04-01 2025-03-31 0001135951 ifrs-full:OtherEnvironmentRelatedProvisionMember 2024-04-01 2025-03-31 0001135951 rdy:CategoryMember rdy:Drl2002PlanMember 2024-04-01 2025-03-31 0001135951 rdy:CategoryBMember rdy:Drl2002PlanMember 2024-04-01 2025-03-31 0001135951 rdy:Drl2002PlanMember 2024-04-01 2025-03-31 0001135951 rdy:CategoryMember rdy:Drl2007PlansMember 2024-04-01 2025-03-31 0001135951 rdy:Drl2007PlansMember 2024-04-01 2025-03-31 0001135951 rdy:DRL2018PlanMember 2024-04-01 2025-03-31 0001135951 ifrs-full:LongtermBorrowingsMember 2024-04-01 2025-03-31 0001135951 ifrs-full:ShorttermBorrowingsMember 2024-04-01 2025-03-31 0001135951 rdy:WorkingsCapitalBorrowingsRubMember 2024-04-01 2025-03-31 0001135951 rdy:WorkingCapitalBorrowingsMxnMember 2024-04-01 2025-03-31 0001135951 rdy:PackingCreditBorrowingsUsdMember 2024-04-01 2025-03-31 0001135951 rdy:WorkingsCapitalBorrowingssInrMember 2024-04-01 2025-03-31 0001135951 rdy:PackingCreditBorrowingsInrMember 2024-04-01 2025-03-31 0001135951 rdy:WorkingsCapitalBorrowingsBrlMember 2024-04-01 2025-03-31 0001135951 rdy:PackingCreditBorrowingsInrOneMember 2024-04-01 2025-03-31 0001135951 ifrs-full:LaterThanSixMonthsAndNotLaterThanOneYearMember rdy:BrazilianRealsMember 2024-04-01 2025-03-31 0001135951 rdy:BrazilianRealsMember 2024-04-01 2025-03-31 0001135951 ifrs-full:NotLaterThanOneMonthMember rdy:BrazilianRealsMember 2024-04-01 2025-03-31 0001135951 ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember rdy:BrazilianRealsMember 2024-04-01 2025-03-31 0001135951 ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember rdy:BrazilianRealsMember 2024-04-01 2025-03-31 0001135951 ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember rdy:RussianRoublesMember 2024-04-01 2025-03-31 0001135951 ifrs-full:NotLaterThanOneMonthMember rdy:UsDollarsMember 2024-04-01 2025-03-31 0001135951 ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember rdy:UsDollarsMember 2024-04-01 2025-03-31 0001135951 ifrs-full:LaterThanSixMonthsAndNotLaterThanOneYearMember rdy:RussianRoublesMember 2024-04-01 2025-03-31 0001135951 ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember rdy:RussianRoublesMember 2024-04-01 2025-03-31 0001135951 rdy:RussianRoublesMember 2024-04-01 2025-03-31 0001135951 ifrs-full:LaterThanSixMonthsAndNotLaterThanOneYearMember rdy:UsDollarsMember 2024-04-01 2025-03-31 0001135951 ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember rdy:UsDollarsMember 2024-04-01 2025-03-31 0001135951 rdy:UsDollarsMember 2024-04-01 2025-03-31 0001135951 ifrs-full:NotLaterThanOneMonthMember rdy:RussianRoublesMember 2024-04-01 2025-03-31 0001135951 ifrs-full:OrdinarySharesMember 2024-04-01 2025-03-31 0001135951 rdy:LeaseLiabilitiesTemporaryDifferencesMember 2024-04-01 2025-03-31 0001135951 rdy:RouAssetTemporaryDifferencesMember 2024-04-01 2025-03-31 0001135951 rdy:OperatingAndOtherTaxLossCarryforwardMember 2024-04-01 2025-03-31 0001135951 rdy:OtherCurrentAssetsAndOtherCurrentLiabilitiesNetdeferredTaxLiabilityAssetMember 2024-04-01 2025-03-31 0001135951 rdy:PropertyPlantAndEquipmentdeferredTaxLiabilityAssetMember 2024-04-01 2025-03-31 0001135951 rdy:OthersdeferredTaxLiabilityAssetMember 2024-04-01 2025-03-31 0001135951 rdy:IntangibleAssetsdeferredTaxLiabilityAssetMember 2024-04-01 2025-03-31 0001135951 rdy:TradeAndOtherReceivablesdeferredTaxLiabilityAssetMember 2024-04-01 2025-03-31 0001135951 rdy:InventorydeferredTaxLiabilityAssetMember 2024-04-01 2025-03-31 0001135951 rdy:OthersSegmentsMember rdy:CostOfRevenuesMember 2024-04-01 2025-03-31 0001135951 rdy:GlobalGenericMember rdy:CostOfRevenuesMember 2024-04-01 2025-03-31 0001135951 rdy:PharmaceuticalServicesAndActiveIngredientMember rdy:CostOfRevenuesMember 2024-04-01 2025-03-31 0001135951 rdy:OncologyMember rdy:GlobalGenericMember 2024-04-01 2025-03-31 0001135951 rdy:OtherGlobalGenericsMember rdy:GlobalGenericMember 2024-04-01 2025-03-31 0001135951 rdy:DiabetologyMember rdy:GlobalGenericMember 2024-04-01 2025-03-31 0001135951 rdy:PainManagementMember rdy:GlobalGenericMember 2024-04-01 2025-03-31 0001135951 rdy:CentralNervousSystemMember rdy:GlobalGenericMember 2024-04-01 2025-03-31 0001135951 rdy:RespiratoryMember rdy:GlobalGenericMember 2024-04-01 2025-03-31 0001135951 rdy:GastrointestinalMember rdy:GlobalGenericMember 2024-04-01 2025-03-31 0001135951 rdy:CardiovascularMember rdy:GlobalGenericMember 2024-04-01 2025-03-31 0001135951 rdy:AntiinfectiveMember rdy:GlobalGenericMember 2024-04-01 2025-03-31 0001135951 rdy:GlobalGenericMember 2024-04-01 2025-03-31 0001135951 rdy:NutraceuticalMember rdy:GlobalGenericMember 2024-04-01 2025-03-31 0001135951 rdy:DermatologyMember rdy:GlobalGenericMember 2024-04-01 2025-03-31 0001135951 rdy:HematologyMember rdy:GlobalGenericMember 2024-04-01 2025-03-31 0001135951 rdy:GenitourinaryMember rdy:PharmaceuticalServicesAndActiveIngredientMember 2024-04-01 2025-03-31 0001135951 rdy:DermatologyMember rdy:PharmaceuticalServicesAndActiveIngredientMember 2024-04-01 2025-03-31 0001135951 rdy:DiabetologyMember rdy:PharmaceuticalServicesAndActiveIngredientMember 2024-04-01 2025-03-31 0001135951 rdy:RespiratoryMember rdy:PharmaceuticalServicesAndActiveIngredientMember 2024-04-01 2025-03-31 0001135951 rdy:AntiInfectiveOneMember rdy:PharmaceuticalServicesAndActiveIngredientMember 2024-04-01 2025-03-31 0001135951 rdy:GastrointestinalMember rdy:PharmaceuticalServicesAndActiveIngredientMember 2024-04-01 2025-03-31 0001135951 rdy:HematologyMember rdy:PharmaceuticalServicesAndActiveIngredientMember 2024-04-01 2025-03-31 0001135951 rdy:PainManagementMember rdy:PharmaceuticalServicesAndActiveIngredientMember 2024-04-01 2025-03-31 0001135951 rdy:PharmaceuticalServicesAndActiveIngredientMember 2024-04-01 2025-03-31 0001135951 rdy:OtherPsaiMember rdy:PharmaceuticalServicesAndActiveIngredientMember 2024-04-01 2025-03-31 0001135951 rdy:OncologyMember rdy:PharmaceuticalServicesAndActiveIngredientMember 2024-04-01 2025-03-31 0001135951 rdy:CardiovascularMember rdy:PharmaceuticalServicesAndActiveIngredientMember 2024-04-01 2025-03-31 0001135951 rdy:CentralNervousSystemMember rdy:PharmaceuticalServicesAndActiveIngredientMember 2024-04-01 2025-03-31 0001135951 ifrs-full:GrossCarryingAmountMember 2024-04-01 2025-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:OtherIntangibleAssetsMember 2024-04-01 2025-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2024-04-01 2025-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:RecipesFormulaeModelsDesignsAndPrototypesMember 2024-04-01 2025-03-31 0001135951 ifrs-full:ClassesOfPropertyPlantAndEquipmentDomain 2024-04-01 2025-03-31 0001135951 ifrs-full:EquityAttributableToOwnersOfParentMember 2024-04-01 2025-03-31 0001135951 ifrs-full:NoncontrollingInterestsMember 2024-04-01 2025-03-31 0001135951 rdy:ActuarialGainsLossesMember 2024-04-01 2025-03-31 0001135951 rdy:SpecialEconomicZoneReinvestmentReserveMember 2024-04-01 2025-03-31 0001135951 ifrs-full:CapitalRedemptionReserveMember 2024-04-01 2025-03-31 0001135951 ifrs-full:ReserveOfCashFlowHedgesMember 2024-04-01 2025-03-31 0001135951 ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember 2024-04-01 2025-03-31 0001135951 rdy:FairValueReserveMember 2024-04-01 2025-03-31 0001135951 ifrs-full:IssuedCapitalMember 2024-04-01 2025-03-31 0001135951 ifrs-full:RetainedEarningsMember 2024-04-01 2025-03-31 0001135951 ifrs-full:ReserveOfSharebasedPaymentsMember 2024-04-01 2025-03-31 0001135951 ifrs-full:TreasurySharesMember 2024-04-01 2025-03-31 0001135951 ifrs-full:SharePremiumMember 2024-04-01 2025-03-31 0001135951 ifrs-full:OtherReservesMember 2024-04-01 2025-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember 2024-04-01 2025-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember ifrs-full:OtherIntangibleAssetsMember 2024-04-01 2025-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember ifrs-full:RecipesFormulaeModelsDesignsAndPrototypesMember 2024-04-01 2025-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2024-04-01 2025-03-31 0001135951 ifrs-full:InterestRateSwapContractMember 2024-04-01 2025-03-31 0001135951 rdy:ProvidentFundBenefitsMember 2024-04-01 2025-03-31 0001135951 rdy:SuperannuationBenefitsMember 2024-04-01 2025-03-31 0001135951 rdy:LandPollutionMember 2024-04-01 2025-03-31 0001135951 rdy:UkSocialSecuriyPlanMember 2024-04-01 2025-03-31 0001135951 rdy:Us401kretirementSavingsPlanMember 2024-04-01 2025-03-31 0001135951 rdy:CategoryBParValueOptionsMember rdy:DrlTwoThousandSevenPlanMember rdy:ExercisepricesRs5Member 2024-04-01 2025-03-31 0001135951 rdy:CategoryBParValueOptionsMember rdy:Drl2002PlanMember rdy:ExercisepricesRs5Member 2024-04-01 2025-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:LandMember 2024-04-01 2025-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:BuildingsMember 2024-04-01 2025-03-31 0001135951 ifrs-full:GrossCarryingAmountMember rdy:PlantAndEquipmentMember 2024-04-01 2025-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:OfficeEquipmentMember 2024-04-01 2025-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:VehiclesMember 2024-04-01 2025-03-31 0001135951 rdy:CategoriesBMember rdy:Drl2007PlansMember 2024-04-01 2025-03-31 0001135951 rdy:CategoriesAMember rdy:Drl2007PlansMember 2024-04-01 2025-03-31 0001135951 rdy:EquitySettledShareBasedPaymentExpenseMember rdy:DrlTwoThousandEighteenPlanMember 2024-04-01 2025-03-31 0001135951 rdy:EquitySettledShareBasedPaymentExpenseMember 2024-04-01 2025-03-31 0001135951 rdy:CashSettledSharebasedPaymentMember 2024-04-01 2025-03-31 0001135951 rdy:NorfloxacinIndiaLitigationMember 2024-04-01 2025-03-31 0001135951 rdy:LoanTwoMember ifrs-full:FloatingInterestRateMember 2024-04-01 2025-03-31 0001135951 rdy:LoanOneMember ifrs-full:FloatingInterestRateMember 2024-04-01 2025-03-31 0001135951 rdy:LoanSixMember ifrs-full:FloatingInterestRateMember 2024-04-01 2025-03-31 0001135951 rdy:LoanFiveMember ifrs-full:FloatingInterestRateMember 2024-04-01 2025-03-31 0001135951 rdy:LoanFourMember ifrs-full:FloatingInterestRateMember 2024-04-01 2025-03-31 0001135951 rdy:LoanThreeMember ifrs-full:FloatingInterestRateMember 2024-04-01 2025-03-31 0001135951 rdy:KunshanRotamReddyPharmaceuticalCo.LimitedMember 2024-04-01 2025-03-31 0001135951 rdy:LacockHoldingsLimitedMember 2024-04-01 2025-03-31 0001135951 rdy:NimbusHealthGmbhMember 2024-04-01 2025-03-31 0001135951 rdy:NorthStarOpCoLimitedFromSeptember302024Member 2024-04-01 2025-03-31 0001135951 rdy:ReddyPharmaItaliaSrlMember 2024-04-01 2025-03-31 0001135951 rdy:ReddyPharmasSasMember 2024-04-01 2025-03-31 0001135951 rdy:SvaasWellnessLimitedFormerlyRegkineticsServicesLimitedMember 2024-04-01 2025-03-31 0001135951 rdy:NorthstarSwitzerlandSARLFromSeptember302024Member 2024-04-01 2025-03-31 0001135951 rdy:O2RenewableEnergyIxPrivateLimitedMember 2024-04-01 2025-03-31 0001135951 rdy:PromiusPharmaLlcMember 2024-04-01 2025-03-31 0001135951 rdy:ReddyHoldingGmbhMember 2024-04-01 2025-03-31 0001135951 rdy:ReddyNetherlandsBvMember 2024-04-01 2025-03-31 0001135951 rdy:ReddyPharmaIberiaSauMember 2024-04-01 2025-03-31 0001135951 rdy:NorthStarSwedenABFromSeptember302024Member 2024-04-01 2025-03-31 0001135951 rdy:DresEnergyPrivateLimitedMember 2024-04-01 2025-03-31 0001135951 rdy:DrlImpexLimitedMember 2024-04-01 2025-03-31 0001135951 rdy:Idea2enterprisesIndiaPvtLimitedMember 2024-04-01 2025-03-31 0001135951 rdy:ImperialOwnersAndLandPossessionsPrivateLimitedFormerlyImperialCreditPrivateLimitedEntityUnderLiquidationMember 2024-04-01 2025-03-31 0001135951 rdy:IndustriasQuimicasFalconDeMexicoSaDeCvMember 2024-04-01 2025-03-31 0001135951 rdy:KunshanRotamReddyMedicineCompanyLimitedMember 2024-04-01 2025-03-31 0001135951 rdy:DrreddysNewZealandLimitedMember 2024-04-01 2025-03-31 0001135951 rdy:DrreddysResearchFoundationMember 2024-04-01 2025-03-31 0001135951 rdy:DrReddysSrlMember 2024-04-01 2025-03-31 0001135951 rdy:DrReddysVenezuelaCAdissolvedonJune52024Member 2024-04-01 2025-03-31 0001135951 rdy:DrReddysDenmarkApSFromOctober42024Member 2024-04-01 2025-03-31 0001135951 rdy:DrReddysNetherlandsBVformerlyDrReddysResearchAndDevelopmentBVMember 2024-04-01 2025-03-31 0001135951 rdy:Dr.ReddysLaboratoriesNewYorkLlc.Member 2024-04-01 2025-03-31 0001135951 rdy:DrReddysLaboratoriesPhilippinesMember 2024-04-01 2025-03-31 0001135951 rdy:DrreddysLaboratoriesRomaniaSrlMember 2024-04-01 2025-03-31 0001135951 rdy:DrreddysLaboratoriesSaMember 2024-04-01 2025-03-31 0001135951 rdy:DrReddysLaboratoriesSasMember 2024-04-01 2025-03-31 0001135951 rdy:DrReddysLaboratoriesTaiwanLimitedMember 2024-04-01 2025-03-31 0001135951 rdy:DrReddysLaboratoriesJapanKkMember 2024-04-01 2025-03-31 0001135951 rdy:DrReddysLaboratoriesKazakhstanLlpMember 2024-04-01 2025-03-31 0001135951 rdy:DrreddysLaboratoriesLlcMember 2024-04-01 2025-03-31 0001135951 rdy:DrReddysLaboratoriesLLCUkraineMember 2024-04-01 2025-03-31 0001135951 rdy:DrReddysLaboratoriesLouisianaLLCDivestedOnMarch212025Member 2024-04-01 2025-03-31 0001135951 rdy:DrReddysLaboratoriesMalaysiaSdnBhdMember 2024-04-01 2025-03-31 0001135951 rdy:DrReddysLaboratoriesthailandMember 2024-04-01 2025-03-31 0001135951 rdy:DrreddysLaboratoriesUkLimitedMember 2024-04-01 2025-03-31 0001135951 rdy:DrreddysLaboratoriesCanadaIncMember 2024-04-01 2025-03-31 0001135951 rdy:DrReddysLaboratoriesChileSpaMember 2024-04-01 2025-03-31 0001135951 rdy:DrreddysLaboratoriesIncMember 2024-04-01 2025-03-31 0001135951 rdy:Dr.ReddysLaboratoriesJamaicaLimitedFromSeptember252023Member 2024-04-01 2025-03-31 0001135951 rdy:DrreddysFarmaceuticaDoBrasilLtdaMember 2024-04-01 2025-03-31 0001135951 rdy:DrReddysFinlandOyFromDecember202024Member 2024-04-01 2025-03-31 0001135951 rdy:Dr.ReddysFormulationsLimitedMember 2024-04-01 2025-03-31 0001135951 rdy:DrreddysLaboratoriesAustraliaPtyLimitedMember 2024-04-01 2025-03-31 0001135951 rdy:DrreddysLaboratoriesEuLimitedMember 2024-04-01 2025-03-31 0001135951 rdy:DrreddysLaboratoriesProprietaryLimitedMember 2024-04-01 2025-03-31 0001135951 rdy:ChirotechTechnologyLimitedDissolvedOnSeptember182024Member 2024-04-01 2025-03-31 0001135951 rdy:CleanRenewableEnergyKK2APrivateLimitedFromJuly312024Member 2024-04-01 2025-03-31 0001135951 rdy:DrReddysBeijingPharmaceuticalCoLimitedMember 2024-04-01 2025-03-31 0001135951 rdy:DrReddysAndNestleHealthScienceLimitedFormerlyDrReddysNutraceuticalsLimitedMember 2024-04-01 2025-03-31 0001135951 rdy:DrreddysBiosciencesLimitedMember 2024-04-01 2025-03-31 0001135951 rdy:DrReddysLaboratoriesEsosTrustMember 2024-04-01 2025-03-31 0001135951 rdy:AurigeneOncologyLimitedFormerlyAurigeneDiscoveryTechnologiesLimitedMember 2024-04-01 2025-03-31 0001135951 rdy:AurigenePharmaceuticalServicesLimitedMember 2024-04-01 2025-03-31 0001135951 rdy:BetaInstitutGemeinnutzigeGmbhMember 2024-04-01 2025-03-31 0001135951 rdy:BetapharmArzneimittelGmbhMember 2024-04-01 2025-03-31 0001135951 rdy:CheminorEmployeesWelfareTrustsMember 2024-04-01 2025-03-31 0001135951 rdy:CheminorInvestmentsLimitedMember 2024-04-01 2025-03-31 0001135951 rdy:AurigeneDiscoveryTechnologiesMalaysiaSdnBhdMember 2024-04-01 2025-03-31 0001135951 rdy:HaleonUkEnterprisesLimitedMember 2024-04-01 2025-03-31 0001135951 rdy:WockhardtLimitedMember 2024-04-01 2025-03-31 0001135951 rdy:ShanghaiHenliusBiotechzincMember 2024-04-01 2025-03-31 0001135951 rdy:NovartisAGMember 2024-04-01 2025-03-31 0001135951 rdy:MaynePharmaGroupLimitedMember 2024-04-01 2025-03-31 0001135951 rdy:UcbIndiaPrivateLimitedAndAffiliatesMember 2024-04-01 2025-03-31 0001135951 rdy:DresEnergyPrivateLimitedMember 2024-04-01 2025-03-31 0001135951 rdy:DRL2018PlanMember rdy:SecuritiesIssuedByTheCompanyMember 2024-04-01 2025-03-31 0001135951 rdy:DRL2018PlanMember 2024-04-01 2025-03-31 0001135951 rdy:DRL2018PlanMember rdy:SecuritiesAcquiredFromSecondaryMarketMember 2024-04-01 2025-03-31 0001135951 rdy:O2RenewableEnergyIxPrivateLimitedMember 2024-04-01 2025-03-31 0001135951 rdy:CleanRenewableEnergyKK2APrivateLimitedMember 2024-04-01 2025-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember ifrs-full:VehiclesMember 2024-04-01 2025-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember ifrs-full:LandMember 2024-04-01 2025-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember ifrs-full:BuildingsMember 2024-04-01 2025-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember rdy:PlantAndEquipmentMember 2024-04-01 2025-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember ifrs-full:OfficeEquipmentMember 2024-04-01 2025-03-31 0001135951 rdy:MayneMember rdy:NuvaringMember 2024-04-01 2025-03-31 0001135951 rdy:NuvaringMember 2024-04-01 2025-03-31 0001135951 rdy:IndiaAndEuropeMember rdy:GlobalGenericsMember 2024-04-01 2025-03-31 0001135951 rdy:RefundLiabilityMember 2024-04-01 2025-03-31 0001135951 rdy:MedicaidMember 2024-04-01 2025-03-31 0001135951 rdy:RebatesMember 2024-04-01 2025-03-31 0001135951 rdy:ChargebacksMember 2024-04-01 2025-03-31 0001135951 rdy:CategoryMember rdy:DrlTwoThousandSevenPlanMember 2024-04-01 2025-03-31 0001135951 rdy:CategoryMember rdy:DrlTwoThousandSevenPlanMember rdy:MiddleRangeOneMember 2024-04-01 2025-03-31 0001135951 rdy:CategoryMember rdy:DrlTwoThousandSevenPlanMember ifrs-full:BottomOfRangeMember 2024-04-01 2025-03-31 0001135951 rdy:CategoryMember rdy:DrlTwoThousandSevenPlanMember ifrs-full:TopOfRangeMember 2024-04-01 2025-03-31 0001135951 rdy:DrlTwoThousandEighteenPlanMember 2024-04-01 2025-03-31 0001135951 rdy:DrlTwoThousandEighteenPlanMember ifrs-full:BottomOfRangeMember 2024-04-01 2025-03-31 0001135951 rdy:DrlTwoThousandEighteenPlanMember ifrs-full:TopOfRangeMember 2024-04-01 2025-03-31 0001135951 dei:AdrMember 2024-04-01 2025-03-31 0001135951 rdy:PriorToStockSplitDrReddysEmployeesStockOptionScheme2018Member 2024-04-01 2025-03-31 0001135951 rdy:AfterStockSplitDrReddysEmployeesStockOptionScheme2018Member 2024-04-01 2025-03-31 0001135951 rdy:AccumulatedDepreciationMember ifrs-full:BuildingsMember 2024-04-01 2025-03-31 0001135951 rdy:AccumulatedDepreciationMember ifrs-full:LandMember 2024-04-01 2025-03-31 0001135951 rdy:AccumulatedDepreciationMember rdy:FurnitureFixturesAndOfficeEquipmentMember 2024-04-01 2025-03-31 0001135951 rdy:AccumulatedDepreciationMember rdy:PlantAndEquipmentMember 2024-04-01 2025-03-31 0001135951 rdy:AccumulatedDepreciationMember ifrs-full:VehiclesMember 2024-04-01 2025-03-31 0001135951 rdy:AccumulatedDepreciationMember 2024-04-01 2025-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:BuildingsMember 2024-04-01 2025-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:LandMember 2024-04-01 2025-03-31 0001135951 ifrs-full:GrossCarryingAmountMember rdy:PlantAndEquipmentMember 2024-04-01 2025-03-31 0001135951 ifrs-full:GrossCarryingAmountMember rdy:FurnitureFixturesAndOfficeEquipmentMember 2024-04-01 2025-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:VehiclesMember 2024-04-01 2025-03-31 0001135951 rdy:PlantAndEquipmentMember ifrs-full:TopOfRangeMember 2024-04-01 2025-03-31 0001135951 ifrs-full:FixturesAndFittingsMember ifrs-full:BottomOfRangeMember 2024-04-01 2025-03-31 0001135951 ifrs-full:FixturesAndFittingsMember ifrs-full:TopOfRangeMember 2024-04-01 2025-03-31 0001135951 ifrs-full:VehiclesMember ifrs-full:BottomOfRangeMember 2024-04-01 2025-03-31 0001135951 ifrs-full:VehiclesMember ifrs-full:TopOfRangeMember 2024-04-01 2025-03-31 0001135951 rdy:FactoryAndAdministrativeBuildingsMember ifrs-full:BottomOfRangeMember 2024-04-01 2025-03-31 0001135951 rdy:FactoryAndAdministrativeBuildingsMember ifrs-full:TopOfRangeMember 2024-04-01 2025-03-31 0001135951 rdy:AncillaryStructuresMember ifrs-full:BottomOfRangeMember 2024-04-01 2025-03-31 0001135951 rdy:AncillaryStructuresMember ifrs-full:TopOfRangeMember 2024-04-01 2025-03-31 0001135951 rdy:PlantAndEquipmentMember ifrs-full:BottomOfRangeMember 2024-04-01 2025-03-31 0001135951 ifrs-full:RecipesFormulaeModelsDesignsAndPrototypesMember ifrs-full:TopOfRangeMember 2024-04-01 2025-03-31 0001135951 ifrs-full:OtherIntangibleAssetsMember ifrs-full:BottomOfRangeMember 2024-04-01 2025-03-31 0001135951 ifrs-full:OtherIntangibleAssetsMember ifrs-full:TopOfRangeMember 2024-04-01 2025-03-31 0001135951 ifrs-full:RecipesFormulaeModelsDesignsAndPrototypesMember ifrs-full:BottomOfRangeMember 2024-04-01 2025-03-31 0001135951 rdy:GlobalGenericsComplexInjectablesMember 2024-04-01 2025-03-31 0001135951 rdy:ExercisePriceOneMember rdy:DrReddysEmployeesStockOptionScheme2018Member 2024-04-01 2025-03-31 0001135951 rdy:ExercisePriceOneMember rdy:PriorToStockSplitDrReddysEmployeesStockOptionScheme2018Member 2024-04-01 2025-03-31 0001135951 rdy:ExercisePriceOneMember rdy:AfterStockSplitDrReddysEmployeesStockOptionScheme2018Member 2024-04-01 2025-03-31 0001135951 rdy:WockhardtLimitedMember 2024-04-01 2025-03-31 0001135951 rdy:ExercisePriceTwoMember rdy:PriorToStockSplitDrReddysEmployeesStockOptionScheme2018Member 2024-04-01 2025-03-31 0001135951 rdy:ExercisePriceTwoMember rdy:AfterStockSplitDrReddysEmployeesStockOptionScheme2018Member 2024-04-01 2025-03-31 0001135951 dei:BusinessContactMember 2024-04-01 2025-03-31 0001135951 ifrs-full:TopOfRangeMember 2024-04-01 2025-03-31 0001135951 rdy:TermLoanFromBankMember currency:INR 2024-04-01 2025-03-31 0001135951 rdy:DrReddysEmployeesStockOptionScheme2018Member 2024-04-01 2025-03-31 0001135951 rdy:ExercisePriceOneMember rdy:DrReddysEmployeesStockOptionScheme2007Member 2024-04-01 2025-03-31 0001135951 rdy:ExercisePriceTwoMember rdy:DrReddysEmployeesStockOptionScheme2007Member 2024-04-01 2025-03-31 0001135951 rdy:AfterStockSplitEmployeesStockOptionSchemeMember 2024-04-01 2025-03-31 0001135951 rdy:DaratumumabBiosimilarMember 2024-04-01 2025-03-31 0001135951 rdy:HenliusMember 2024-04-01 2025-03-31 0001135951 rdy:DenosumabMember 2024-04-01 2025-03-31 0001135951 rdy:HelinormMember 2024-04-01 2025-03-31 0001135951 rdy:Drl2007PlansMember ifrs-full:BottomOfRangeMember 2024-04-01 2025-03-31 0001135951 rdy:Drl2007PlansMember ifrs-full:TopOfRangeMember 2024-04-01 2025-03-31 0001135951 rdy:Drl2002PlanMember ifrs-full:BottomOfRangeMember 2024-04-01 2025-03-31 0001135951 rdy:Drl2002PlanMember ifrs-full:TopOfRangeMember 2024-04-01 2025-03-31 0001135951 rdy:HaleonMember 2024-04-01 2025-03-31 0001135951 rdy:NestlIndiaMember 2024-04-01 2025-03-31 0001135951 rdy:NestleIndiaMember 2024-04-01 2025-03-31 0001135951 rdy:TransitionalDistributionServicesAgreementMember rdy:HaleonMember 2024-04-01 2025-03-31 0001135951 rdy:TransitionalDistributionServicesAgreementMember ifrs-full:SellingGeneralAndAdministrativeExpenseMember rdy:HaleonMember 2024-04-01 2025-03-31 0001135951 rdy:DrreddysLaboratoriesLouisianaLlcMember 2024-04-01 2025-03-31 0001135951 rdy:AssetAcquisitionAgreementMember rdy:MaynePharmaGroupLimitedMember rdy:PipelineProductsMember 2023-02-27 0001135951 rdy:AssetAcquisitionAgreementMember rdy:MaynePharmaGroupLimitedMember 2023-02-27 0001135951 rdy:AssetAcquisitionAgreementMember rdy:MaynePharmaGroupLimitedMember rdy:ApprovedNonMarketedProductsMember 2023-02-27 0001135951 rdy:AssetAcquisitionAgreementMember rdy:MaynePharmaGroupLimitedMember ifrs-full:MajorPurchasesOfAssetsMember 2023-04-06 0001135951 rdy:KunshanRotamReddyPharmaceuticalsCoLimitedMember 2023-03-31 0001135951 rdy:EmployeeBenefitObligationsMember rdy:ParentCompanyGratuityPlanMember 2023-03-31 0001135951 rdy:GlobalGenericsComplexInjectablesMember 2023-03-31 0001135951 rdy:DresEnergyPrivateLimitedMember 2023-03-31 0001135951 rdy:O2RenewableEnergyIxPrivateLimitedMember 2023-03-31 0001135951 rdy:CleanRenewableEnergyKK2APrivateLimitedMember 2023-03-31 0001135951 rdy:CardiovascularMember 2017-07-27 0001135951 rdy:CardiovascularMember 2017-08-08 0001135951 rdy:CardiovascularMember 2017-09-13 0001135951 rdy:CardiovascularMember 2017-09-15 0001135951 rdy:FuelSurchargeAdjustmentsMember 2008-04-01 2013-03-31 0001135951 rdy:FuelSurchargeAdjustmentsMember 2012-04-01 2013-03-31 0001135951 rdy:FuelSurchargeAdjustmentsMember 2016-04-01 2016-06-30 0001135951 rdy:DrReddysHoldingsLimitedMember 2019-07-29 2019-07-29 0001135951 rdy:EventsAfterReportingPeriodMember 2022-04-08 2022-04-08 0001135951 rdy:EventsAfterReportingPeriodMember 2022-04-08 0001135951 rdy:NorfloxacinIndiaLitigationMember 2006-03-31 0001135951 rdy:NorfloxacinIndiaLitigationMember 2008-03-31 0001135951 rdy:OptionOneOnMaySixthTwentyTwentyFourMember 2024-05-06 2024-05-06 0001135951 rdy:OptionTwoOnMaySixthTwentyTwentyFourMember 2024-05-06 2024-05-06 0001135951 rdy:OptionOneOnOctoberTwentySixthTwentyTwentyThreeMember 2023-10-26 2023-10-26 0001135951 rdy:OptionTwoOnOctoberTwentySixthTwentyTwentyThreeMember 2023-10-26 2023-10-26 0001135951 rdy:OptionTwoOnNinthMayTwoThousandTwentyThreeMember 2023-05-09 2023-05-09 0001135951 rdy:OptionOneOnNinthMayTwoThousandTwentyThreeMember 2023-05-09 2023-05-09 0001135951 rdy:NestleIndiaMember 2024-08-01 2024-08-01 0001135951 rdy:DrReddysLaboratoriesMember 2024-08-01 2024-08-01 0001135951 rdy:NestleIndiaMember rdy:NutraceuticalsSubsidiaryMember 2024-08-01 2024-08-01 0001135951 rdy:DrReddysLaboratoriesMember rdy:NutraceuticalsSubsidiaryMember 2024-08-01 2024-08-01 0001135951 rdy:HaleonMember rdy:NorthstarSwitzerlandSarlMember 2024-06-26 2024-06-26 0001135951 rdy:HaleonMember 2024-06-26 0001135951 rdy:HaleonMember rdy:NorthstarSwitzerlandSarlMember 2024-06-26 0001135951 ifrs-full:RetainedEarningsMember 2022-03-31 0001135951 rdy:ActuarialGainsLossesMember 2022-03-31 0001135951 rdy:DebentureRedemptionReserveMember 2022-03-31 0001135951 rdy:SpecialEconomicZoneReinvestmentReserveMember 2022-03-31 0001135951 ifrs-full:CapitalRedemptionReserveMember 2022-03-31 0001135951 ifrs-full:ReserveOfSharebasedPaymentsMember 2022-03-31 0001135951 ifrs-full:TreasurySharesMember 2022-03-31 0001135951 ifrs-full:SharePremiumMember 2022-03-31 0001135951 ifrs-full:IssuedCapitalMember 2022-03-31 0001135951 ifrs-full:ReserveOfCashFlowHedgesMember 2022-03-31 0001135951 ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember 2022-03-31 0001135951 rdy:FairValueReserveMember 2022-03-31 0001135951 rdy:ChargebacksMember 2022-03-31 0001135951 rdy:RefundLiabilityMember 2022-03-31 0001135951 rdy:MedicaidMember 2022-03-31 0001135951 rdy:RebatesMember 2022-03-31 0001135951 rdy:RefundLiabilityMember 2023-03-31 0001135951 rdy:MedicaidMember 2023-03-31 0001135951 rdy:RebatesMember 2023-03-31 0001135951 rdy:ChargebacksMember 2023-03-31 0001135951 ifrs-full:OtherIntangibleAssetsMember 2023-03-31 0001135951 ifrs-full:RecipesFormulaeModelsDesignsAndPrototypesMember 2023-03-31 0001135951 ifrs-full:CustomerrelatedIntangibleAssetsMember 2023-03-31 0001135951 rdy:FairValueReserveMember 2023-03-31 0001135951 ifrs-full:ReserveOfSharebasedPaymentsMember 2023-03-31 0001135951 ifrs-full:TreasurySharesMember 2023-03-31 0001135951 ifrs-full:SharePremiumMember 2023-03-31 0001135951 ifrs-full:IssuedCapitalMember 2023-03-31 0001135951 ifrs-full:RetainedEarningsMember 2023-03-31 0001135951 rdy:ActuarialGainsLossesMember 2023-03-31 0001135951 rdy:SpecialEconomicZoneReinvestmentReserveMember 2023-03-31 0001135951 ifrs-full:CapitalRedemptionReserveMember 2023-03-31 0001135951 ifrs-full:ReserveOfCashFlowHedgesMember 2023-03-31 0001135951 ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember 2023-03-31 0001135951 rdy:DebentureRedemptionReserveMember 2023-03-31 0001135951 rdy:ExcludingCapitalworkinprogressMember 2023-03-31 0001135951 rdy:ExcludingCapitalworkinprogressMember ifrs-full:VehiclesMember 2023-03-31 0001135951 rdy:ExcludingCapitalworkinprogressMember ifrs-full:OfficeEquipmentMember 2023-03-31 0001135951 rdy:ExcludingCapitalworkinprogressMember rdy:PlantAndEquipmentMember 2023-03-31 0001135951 rdy:ExcludingCapitalworkinprogressMember ifrs-full:BuildingsMember 2023-03-31 0001135951 rdy:ExcludingCapitalworkinprogressMember ifrs-full:LandMember 2023-03-31 0001135951 ifrs-full:LandMember 2023-03-31 0001135951 rdy:FurnitureFixturesAndOfficeEquipmentMember 2023-03-31 0001135951 ifrs-full:VehiclesMember 2023-03-31 0001135951 rdy:PlantAndEquipmentMember 2023-03-31 0001135951 ifrs-full:BuildingsMember 2023-03-31 0001135951 ifrs-full:IntangibleAssetsUnderDevelopmentMember 2023-03-31 0001135951 rdy:GratuityBenefitsOfParentMember 2023-03-31 0001135951 ifrs-full:LongtermBorrowingsMember 2023-03-31 0001135951 ifrs-full:ShorttermBorrowingsMember 2023-03-31 0001135951 rdy:ParentCompanyGratuityPlanMember 2023-03-31 0001135951 ifrs-full:OrdinarySharesMember 2023-03-31 0001135951 rdy:TradeAndOtherReceivablesdeferredTaxLiabilityAssetMember 2023-03-31 0001135951 rdy:RouAssetTemporaryDifferencesMember 2023-03-31 0001135951 rdy:PropertyPlantAndEquipmentdeferredTaxLiabilityAssetMember 2023-03-31 0001135951 rdy:OthersdeferredTaxLiabilityAssetMember 2023-03-31 0001135951 rdy:IntangibleAssetsdeferredTaxLiabilityAssetMember 2023-03-31 0001135951 rdy:LeaseLiabilitiesTemporaryDifferencesMember 2023-03-31 0001135951 rdy:InventorydeferredTaxLiabilityAssetMember 2023-03-31 0001135951 rdy:OperatingAndOtherTaxLossCarryforwardMember 2023-03-31 0001135951 rdy:OtherCurrentAssetsAndOtherCurrentLiabilitiesNetdeferredTaxLiabilityAssetMember 2023-03-31 0001135951 ifrs-full:GrossCarryingAmountMember 2023-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:OtherIntangibleAssetsMember 2023-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2023-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:RecipesFormulaeModelsDesignsAndPrototypesMember 2023-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember 2023-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember ifrs-full:OtherIntangibleAssetsMember 2023-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2023-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember ifrs-full:RecipesFormulaeModelsDesignsAndPrototypesMember 2023-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember ifrs-full:LandMember 2023-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember ifrs-full:BuildingsMember 2023-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember rdy:PlantAndEquipmentMember 2023-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember ifrs-full:OfficeEquipmentMember 2023-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember ifrs-full:VehiclesMember 2023-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:OfficeEquipmentMember 2023-03-31 0001135951 ifrs-full:GrossCarryingAmountMember rdy:PlantAndEquipmentMember 2023-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:BuildingsMember 2023-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:LandMember 2023-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:VehiclesMember 2023-03-31 0001135951 rdy:CategoryBParValueOptionsMember rdy:Drl2002PlanMember rdy:ExercisepricesRs5Member 2023-03-31 0001135951 rdy:CategoryBParValueOptionsMember rdy:DrlTwoThousandSevenPlanMember rdy:ExercisepricesRs5Member 2023-03-31 0001135951 rdy:MedicaidMember 2024-03-31 0001135951 rdy:ChargebacksMember 2024-03-31 0001135951 rdy:RebatesMember 2024-03-31 0001135951 rdy:CategoryMember rdy:DrlTwoThousandSevenPlanMember 2023-03-31 0001135951 rdy:CategoryMember rdy:DrlTwoThousandSevenPlanMember ifrs-full:TopOfRangeMember 2023-03-31 0001135951 rdy:CategoryMember rdy:DrlTwoThousandSevenPlanMember ifrs-full:BottomOfRangeMember 2023-03-31 0001135951 rdy:DrlTwoThousandEighteenPlanMember 2023-03-31 0001135951 rdy:DrlTwoThousandEighteenPlanMember ifrs-full:BottomOfRangeMember 2023-03-31 0001135951 rdy:DrlTwoThousandEighteenPlanMember ifrs-full:TopOfRangeMember 2023-03-31 0001135951 ifrs-full:LongtermBorrowingsMember 2024-03-31 0001135951 ifrs-full:ShorttermBorrowingsMember 2024-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:VehiclesMember 2023-03-31 0001135951 ifrs-full:GrossCarryingAmountMember rdy:FurnitureFixturesAndOfficeEquipmentMember 2023-03-31 0001135951 ifrs-full:GrossCarryingAmountMember rdy:PlantAndEquipmentMember 2023-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:BuildingsMember 2023-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:LandMember 2023-03-31 0001135951 rdy:AccumulatedDepreciationMember rdy:PlantAndEquipmentMember 2023-03-31 0001135951 rdy:AccumulatedDepreciationMember rdy:FurnitureFixturesAndOfficeEquipmentMember 2023-03-31 0001135951 rdy:AccumulatedDepreciationMember ifrs-full:VehiclesMember 2023-03-31 0001135951 rdy:AccumulatedDepreciationMember 2023-03-31 0001135951 rdy:AccumulatedDepreciationMember ifrs-full:LandMember 2023-03-31 0001135951 rdy:AccumulatedDepreciationMember ifrs-full:BuildingsMember 2023-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:RecipesFormulaeModelsDesignsAndPrototypesMember 2024-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2024-03-31 0001135951 ifrs-full:RecipesFormulaeModelsDesignsAndPrototypesMember 2024-03-31 0001135951 ifrs-full:OtherIntangibleAssetsMember 2024-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember ifrs-full:OtherIntangibleAssetsMember 2024-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember 2024-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2024-03-31 0001135951 ifrs-full:CustomerrelatedIntangibleAssetsMember 2024-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember ifrs-full:RecipesFormulaeModelsDesignsAndPrototypesMember 2024-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:OtherIntangibleAssetsMember 2024-03-31 0001135951 ifrs-full:GrossCarryingAmountMember 2024-03-31 0001135951 ifrs-full:RetainedEarningsMember 2024-03-31 0001135951 rdy:ActuarialGainsLossesMember 2024-03-31 0001135951 rdy:SpecialEconomicZoneReinvestmentReserveMember 2024-03-31 0001135951 ifrs-full:ReserveOfCashFlowHedgesMember 2024-03-31 0001135951 ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember 2024-03-31 0001135951 rdy:FairValueReserveMember 2024-03-31 0001135951 ifrs-full:ReserveOfSharebasedPaymentsMember 2024-03-31 0001135951 ifrs-full:TreasurySharesMember 2024-03-31 0001135951 ifrs-full:SharePremiumMember 2024-03-31 0001135951 ifrs-full:IssuedCapitalMember 2024-03-31 0001135951 ifrs-full:CapitalRedemptionReserveMember 2024-03-31 0001135951 rdy:DebentureRedemptionReserveMember 2024-03-31 0001135951 ifrs-full:IntangibleAssetsUnderDevelopmentMember 2024-03-31 0001135951 rdy:ExcludingCapitalworkinprogressMember 2024-03-31 0001135951 rdy:ExcludingCapitalworkinprogressMember ifrs-full:LandMember 2024-03-31 0001135951 rdy:ExcludingCapitalworkinprogressMember ifrs-full:BuildingsMember 2024-03-31 0001135951 rdy:ExcludingCapitalworkinprogressMember rdy:PlantAndEquipmentMember 2024-03-31 0001135951 rdy:ExcludingCapitalworkinprogressMember ifrs-full:OfficeEquipmentMember 2024-03-31 0001135951 rdy:ExcludingCapitalworkinprogressMember ifrs-full:VehiclesMember 2024-03-31 0001135951 ifrs-full:ConstructionInProgressMember 2024-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember ifrs-full:BuildingsMember 2024-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember rdy:PlantAndEquipmentMember 2024-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember ifrs-full:OfficeEquipmentMember 2024-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember ifrs-full:VehiclesMember 2024-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:BuildingsMember 2024-03-31 0001135951 ifrs-full:GrossCarryingAmountMember rdy:PlantAndEquipmentMember 2024-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:OfficeEquipmentMember 2024-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:VehiclesMember 2024-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember ifrs-full:LandMember 2024-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:LandMember 2024-03-31 0001135951 rdy:PropertyPlantAndEquipmentdeferredTaxLiabilityAssetMember 2024-03-31 0001135951 rdy:IntangibleAssetsdeferredTaxLiabilityAssetMember 2024-03-31 0001135951 rdy:OthersdeferredTaxLiabilityAssetMember 2024-03-31 0001135951 rdy:InventorydeferredTaxLiabilityAssetMember 2024-03-31 0001135951 rdy:TradeAndOtherReceivablesdeferredTaxLiabilityAssetMember 2024-03-31 0001135951 rdy:OperatingAndOtherTaxLossCarryforwardMember 2024-03-31 0001135951 rdy:OtherCurrentAssetsAndOtherCurrentLiabilitiesNetdeferredTaxLiabilityAssetMember 2024-03-31 0001135951 rdy:LeaseLiabilitiesTemporaryDifferencesMember 2024-03-31 0001135951 rdy:RouAssetTemporaryDifferencesMember 2024-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:VehiclesMember 2024-03-31 0001135951 rdy:AccumulatedDepreciationMember ifrs-full:VehiclesMember 2024-03-31 0001135951 rdy:AccumulatedDepreciationMember 2024-03-31 0001135951 rdy:AccumulatedDepreciationMember ifrs-full:LandMember 2024-03-31 0001135951 rdy:PlantAndEquipmentMember 2024-03-31 0001135951 ifrs-full:BuildingsMember 2024-03-31 0001135951 ifrs-full:LandMember 2024-03-31 0001135951 ifrs-full:VehiclesMember 2024-03-31 0001135951 rdy:FurnitureFixturesAndOfficeEquipmentMember 2024-03-31 0001135951 rdy:AccumulatedDepreciationMember rdy:PlantAndEquipmentMember 2024-03-31 0001135951 rdy:AccumulatedDepreciationMember ifrs-full:BuildingsMember 2024-03-31 0001135951 rdy:AccumulatedDepreciationMember rdy:FurnitureFixturesAndOfficeEquipmentMember 2024-03-31 0001135951 ifrs-full:GrossCarryingAmountMember rdy:FurnitureFixturesAndOfficeEquipmentMember 2024-03-31 0001135951 ifrs-full:GrossCarryingAmountMember rdy:PlantAndEquipmentMember 2024-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:BuildingsMember 2024-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:LandMember 2024-03-31 0001135951 ifrs-full:LegalProceedingsProvisionMember 2024-03-31 0001135951 ifrs-full:OtherEnvironmentRelatedProvisionMember 2024-03-31 0001135951 ifrs-full:RefundsProvisionMember 2024-03-31 0001135951 ifrs-full:OtherReservesMember 2024-03-31 0001135951 ifrs-full:NoncontrollingInterestsMember 2024-03-31 0001135951 ifrs-full:EquityAttributableToOwnersOfParentMember 2024-03-31 0001135951 rdy:MedicaidMember 2025-03-31 0001135951 rdy:RebatesMember 2025-03-31 0001135951 rdy:ChargebacksMember 2025-03-31 0001135951 ifrs-full:LongtermBorrowingsMember 2025-03-31 0001135951 ifrs-full:ShorttermBorrowingsMember 2025-03-31 0001135951 ifrs-full:RecipesFormulaeModelsDesignsAndPrototypesMember 2025-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember ifrs-full:RecipesFormulaeModelsDesignsAndPrototypesMember 2025-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember ifrs-full:OtherIntangibleAssetsMember 2025-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember 2025-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2025-03-31 0001135951 ifrs-full:CustomerrelatedIntangibleAssetsMember 2025-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:RecipesFormulaeModelsDesignsAndPrototypesMember 2025-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2025-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:OtherIntangibleAssetsMember 2025-03-31 0001135951 ifrs-full:GrossCarryingAmountMember 2025-03-31 0001135951 ifrs-full:OtherIntangibleAssetsMember 2025-03-31 0001135951 ifrs-full:NoncontrollingInterestsMember 2025-03-31 0001135951 ifrs-full:OtherReservesMember 2025-03-31 0001135951 ifrs-full:RetainedEarningsMember 2025-03-31 0001135951 ifrs-full:SharePremiumMember 2025-03-31 0001135951 ifrs-full:IssuedCapitalMember 2025-03-31 0001135951 rdy:ActuarialGainsLossesMember 2025-03-31 0001135951 ifrs-full:CapitalRedemptionReserveMember 2025-03-31 0001135951 ifrs-full:EquityAttributableToOwnersOfParentMember 2025-03-31 0001135951 rdy:SpecialEconomicZoneReinvestmentReserveMember 2025-03-31 0001135951 ifrs-full:ReserveOfCashFlowHedgesMember 2025-03-31 0001135951 ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember 2025-03-31 0001135951 rdy:FairValueReserveMember 2025-03-31 0001135951 ifrs-full:ReserveOfSharebasedPaymentsMember 2025-03-31 0001135951 ifrs-full:TreasurySharesMember 2025-03-31 0001135951 ifrs-full:IntangibleAssetsUnderDevelopmentMember 2025-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:BuildingsMember 2025-03-31 0001135951 rdy:ExcludingCapitalworkinprogressMember ifrs-full:LandMember 2025-03-31 0001135951 rdy:ExcludingCapitalworkinprogressMember ifrs-full:BuildingsMember 2025-03-31 0001135951 rdy:ExcludingCapitalworkinprogressMember rdy:PlantAndEquipmentMember 2025-03-31 0001135951 rdy:ExcludingCapitalworkinprogressMember ifrs-full:OfficeEquipmentMember 2025-03-31 0001135951 rdy:ExcludingCapitalworkinprogressMember ifrs-full:VehiclesMember 2025-03-31 0001135951 rdy:ExcludingCapitalworkinprogressMember 2025-03-31 0001135951 ifrs-full:ConstructionInProgressMember 2025-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:LandMember 2025-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember ifrs-full:VehiclesMember 2025-03-31 0001135951 ifrs-full:GrossCarryingAmountMember rdy:PlantAndEquipmentMember 2025-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:OfficeEquipmentMember 2025-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:VehiclesMember 2025-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember ifrs-full:LandMember 2025-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember ifrs-full:BuildingsMember 2025-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember rdy:PlantAndEquipmentMember 2025-03-31 0001135951 rdy:AccumulatedDepreciationAndImpairmentMember ifrs-full:OfficeEquipmentMember 2025-03-31 0001135951 rdy:OthersdeferredTaxLiabilityAssetMember 2025-03-31 0001135951 rdy:InventorydeferredTaxLiabilityAssetMember 2025-03-31 0001135951 rdy:TradeAndOtherReceivablesdeferredTaxLiabilityAssetMember 2025-03-31 0001135951 rdy:OperatingAndOtherTaxLossCarryforwardMember 2025-03-31 0001135951 rdy:OtherCurrentAssetsAndOtherCurrentLiabilitiesNetdeferredTaxLiabilityAssetMember 2025-03-31 0001135951 rdy:LeaseLiabilitiesTemporaryDifferencesMember 2025-03-31 0001135951 rdy:RouAssetTemporaryDifferencesMember 2025-03-31 0001135951 rdy:PropertyPlantAndEquipmentdeferredTaxLiabilityAssetMember 2025-03-31 0001135951 rdy:IntangibleAssetsdeferredTaxLiabilityAssetMember 2025-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:VehiclesMember 2025-03-31 0001135951 rdy:AccumulatedDepreciationMember ifrs-full:VehiclesMember 2025-03-31 0001135951 rdy:AccumulatedDepreciationMember 2025-03-31 0001135951 rdy:AccumulatedDepreciationMember ifrs-full:LandMember 2025-03-31 0001135951 rdy:PlantAndEquipmentMember 2025-03-31 0001135951 rdy:FurnitureFixturesAndOfficeEquipmentMember 2025-03-31 0001135951 ifrs-full:VehiclesMember 2025-03-31 0001135951 rdy:AccumulatedDepreciationMember ifrs-full:BuildingsMember 2025-03-31 0001135951 ifrs-full:BuildingsMember 2025-03-31 0001135951 ifrs-full:LandMember 2025-03-31 0001135951 ifrs-full:GrossCarryingAmountMember rdy:PlantAndEquipmentMember 2025-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:BuildingsMember 2025-03-31 0001135951 ifrs-full:GrossCarryingAmountMember ifrs-full:LandMember 2025-03-31 0001135951 rdy:AccumulatedDepreciationMember rdy:FurnitureFixturesAndOfficeEquipmentMember 2025-03-31 0001135951 rdy:AccumulatedDepreciationMember rdy:PlantAndEquipmentMember 2025-03-31 0001135951 ifrs-full:GrossCarryingAmountMember rdy:FurnitureFixturesAndOfficeEquipmentMember 2025-03-31 iso4217:INR xbrli:shares iso4217:USD xbrli:pure utr:Year iso4217:EUR iso4217:RUB iso4217:GBP iso4217:INR xbrli:shares rdy:INRPerUSD iso4217:USD xbrli:shares rdy:Number iso4217:INR utr:acre utr:acre utr:Month rdy:Pipeline_Products rdy:CommercialProducts rdy:Approved_Non-marketed_Products utr:M